Oceania Healthcare Limited logo

Oceania delivers improved performance despite COVID-19

Half Year Results28 November 2021OCAHealthcare

MEDIA RELEASE
29 November 2021


OCEANIA DELIVERS IMPROVED PERFORMANCE DESPITE COVID-19 BACKDROP


Oceania today announced unaudited proforma Underlying Earnings before interest, tax,

depreciation and amortisation (EBITDA) of $36.5m for the six month period ended 30

September 2021, a 19.7%, ($6.0m) increase on the six month period ended 30 September

2020

1

.


Highlights:

• A 19.7% increase ($6.0m) in unaudited [proforma] underlying EBITDA compared to

the six month period ended 30 September 2020.

• Aged care business continued to perform well throughout the period despite COVID-

19 disruptions.

• Sales volumes (for both independent living apartments and villas, as well as care

suites) being 10.6% ahead of the six month period ended 30 September 2020,

despite ongoing COVID-19 lockdown restrictions.

• Completion of the acquisition of Waterford (Hobsonville Point, Auckland) in April

2021 and a resource consent for 50 independent living apartments and a basement

carpark has been secured.

• The completion of 49 apartments at Eden (Auckland) in April 2021 and eight villas at

Gracelands (Hastings) in September 2021.

• 545 units (apartments, villas and care suites) under construction as at 30 September

2021.

• Oceania’s total assets are now $2.1b, representing 9.7% growth since 31 March

2021.

• Entry into a conditional sale and purchase agreement to acquire land adjacent to our

Franklin site.

• Completion of a heavily oversubscribed retail bond offer in August 2021, raising

$100m.

• Appointment of Rob Hamilton and Peter Dufaur as independent Directors.

• Appointment of Andrew Buckingham as Group General Manager Property &

Development.


1

On 21 April 2020 the Group claimed, and received payment of, a COVID-19 wage subsidy totalling $1.8m. This amount has

subsequently been repaid in full on 18 May 2021 and as a result has been excluded from proforma results in this media release. This

proforma adjustment increases underlying EBITDA and underlying NPAT in relation to the six month period to 30 September 2021 by

$1.8m and reduces the underlying EBITDA and underlying NPAT position in relation to the six month period to 30 September 2020 by

$1.8m.







• Interim dividend of 2.1 cents per share (not imputed) announced (30 November

2020: 1.3 cents). This will have a record date of 6 December 2021 and will be paid

on 20 December 2021. The Dividend Reinvestment Plan will apply to this dividend.


As a result of Oceania previously changing its balance date to 31 March, the comparative

trading performance noted below is reported on the basis of the six month period to 30

September 2021 compared to the six month period to 30 September 2020:

30 September 2021 unaudited non-GAAP six months trading measures vs six months

to 30 September 2020

$m’s


6 months to 30

September

2021

6 months to

30 September

2020

Growth

$m %

Underlying EBITDA (6 v 6 proforma) 36.5 30.5 6.0 19.7%

Underlying NPAT (6 v 6 proforma) 27.5 22.5 5.0 22.2%

Sales 230 208 22 10.6%

Occupancy 92.5% 91.1%


Statutory measures for the six month period to 30 September 2021 are reported below

compared to the six month period to 30 November 2020.

30 September 2021 unaudited GAAP six month statutory measures vs six months to

30 November 2020

$m’s


6 months to 30

September

2021

6 months to

30 November

2020

Growth

$m %

Operating Revenue (6 v 6 stat) 113.9 103.9 10.0 9.6%

Reported NPAT (6 v 6 stat) 36.9 24.8 12.1 48.8%

Operating Cashflow (6 v 6 stat) 52.5 74.5 (22.0) (29.5%)

Total Assets (Sept v March stat) 2,064.3 1,882.2 182.1 9.7%

Dividend (cents per share) 2.1 1.3


Oceania CEO Brent Pattison advised that “Oceania has continued to provide a safe, vibrant

and well connected community for our residents despite the extended Governmental

restrictions and costs associated with COVID-19. The business has responded well through

high levels of vaccination, regular communications with staff, residents and their families, as

well as a significant investment in surveillance, including declarations, online bookings and

saliva testing.”

Oceania has been working with Government officials and Ministry of Health representatives

with regard to health policy. Oceania has also taken an industry leadership position in







calling for our Auckland residents to be allowed to reconnect with their loved ones safely.

Oceania remains well-prepared to manage any infections that occur at its sites, with

industry-leading infection control policies and a highly experienced clinical team.

Mr Pattison explained that “Prior to the Alert Level Four lockdown being announced on 17

August 2021, sales volumes were strong and development activities were progressing well.

The extended lockdowns, particularly in the Auckland region, have temporarily impacted

Oceania’s sales, delayed building works and have added direct costs associated with

COVID-19.”

Village sales have remained strong throughout the period, despite ongoing COVID-19

restrictions. In the six months to 30 September 2021, there was a total of 102 independent

living (apartment and villa) sales, comprising 57 new sales and 45 resales. This is an

increase of 25.9% from the six month period ended 30 September 2020.

Oceania’s total assets increased to $2.1 billion, up 9.7% ($182.1m) on 31 March 2021,

primarily due to significant capital expenditure and the acquisition of the Waterford and

Franklin sites during the period.

“We have continued to make good progress with the execution of our development pipeline

during the six month period to 30 September 2021, despite the challenges presented by the

COVID-19 lockdown restrictions. As at 30 September 2021, there were 545 units under

construction across New Zealand.” said Mr Pattison.

The appointment of Andrew Buckingham as Group General Manager Property &

Development is a strategic appointment that will further enhance Oceania’s performance in

this area.

Oceania’s total funding positions the company well for future growth. A heavily

oversubscribed seven year retail bond issue of $100m in September 2021, following a

capital raise of $100m undertaken in March/April 2021, and Oceania’s inaugural seven year

retail bond issue in October 2020.

Oceania Chair Liz Coutts noted “We were delighted to have welcomed Rob Hamilton and

Peter Dufaur to the Board as independent Directors during September 2021. They bring an

extensive range of skills and we are looking forward to them making a significant contribution

to the future performance and growth of Oceania.”

Mrs Coutts advises the Board declared an interim dividend of 2.1 cents per share

(unimputed) (30 November 2020: 1.3 cents). The record date for the dividend is 6

December 2021 and the payment date is 20 December 2021. The Dividend Reinvestment

Plan will apply to the dividend payable on 20 December 2021 at a discount of 2.5% to the

volume weighted average price of shares sold on the NZX Main Board over the period of the

five trading days starting on 3 December 2021.

ENDS


For all enquiries, please email investor@oceaniahealthcare.co.nz or phone 0800 333 688

---

Believe
in b et t er.

INTERIM REPORT 2022

Change of balance date 02
At a glance 04

Trading highlights 06

Chair and CEO's report 08

Three year summary 17

Consolidated Interim

Financial statements 18

Notes to the Consolidated

Interim Financial Statements 23

Independent Auditor's Review Report 67

Oceania Healthcare
|

Interim Report 2021

01

01

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

In the six months to 30 September

2021, Oceania has achieved a

20% growth in unaudited underlying

EBITDA compared to the prior

corresponding period, with a solid

performance across its sales and

developments despite the ongoing

COVID-19 restrictions. The business

has responded well through high

levels of vaccination, regular

communications with staff, residents

and their families, as well as a

significant investment in surveillance.


During the six month period to 30 September 2021, New Zealand has been subject to Alert

Level 3 restrictions or higher for a total of 21 days (12% of the reporting period). In addition

to national lockdowns the Auckland region has been subject to Alert Level 3 restrictions or

higher for a further 23 days (13% of the reporting period) as depicted below.

CHANGE OF BALANCE DATE

This represents the first Interim Report since the change

of balance date to 31 March.

18 August 2021 —

31 August 2021

1 September 2021 —

7 September 2021

LEVEL 4 — NZ

1 September 2021 —

21 September 2021

LEVEL 4 — AKL

22 September 2021 —

30 September 2021

LEVEL 3 — AKL

LEVEL 3 — NZ EXCL AKL

7 September 2021 —

30 September 2021

LEVEL 2 — NZ EXCL AKL

2020

2021

26 March 2020 —

27 April 2020

12 August 2020 —

30 August 2020

31 August 2020 —

23 September 2020

28 April 2020 —

13 May 2020

LEVEL 4 — NZLEVEL 3 — AKL

1 APRIL 2020

30 SEPTEMBER 2020

30 SEPTEMBER 2021

1 APRIL 2021

LEVEL 2.5 — AKLLEVEL 3 — NZ

02

OCEANIAINTERIM REPORT 2022


The proforma comparative underlying earnings position

is set out below.

Financial Metrics

The following six month trading position represents the trading position of the

company. The periods represent:

— six months to 30 September 2021; and

— six months to 30 September 2020 (comparative period)

This forms the basis of the trading highlights pages in the Interim Report.

Underlying earnings six month comparative position

$NZ000’s

Unaudited

6 months to

September 2021

Unaudited

6 months to

September 2020

Care

10,9919,135

Village operating

11,399 7,646

Resales cap gain

10,639 6,201

Development margin

15,252 16,782

Corporate

1


(11,814) (9,253)

Group U/L EBITDA

36,467 30,511

Interest

(3,900) (3,622)

Depreciation

(5,059) (4,351)

Underlying NPAT

27,508 22,538

Care Suite depreciation

(4,807) (3,408)

Adjusted Underlying NPAT

22,701 19,130


Occupied beds per day

2,336 2,273

Effective bed capacity per day

2,526 2,495

Effective occupancy (%)

92.5% 91.1%

Existing ORAs sold

45 24

New ORAs sold

57 57

Existing Care Suites sold

84 62

New Care Suites sold

44 65

Total ORAs sold

230 208

03

CHANGE OF BALANCE DATE

1

On 21 April 2020 the Group claimed, and received payment of, a COVID-19 wage subsidy

totalling $1.8m. This amount has subsequently been repaid in full on 18 May 2021 and as a result

has been excluded from the table above. This proforma adjustment increases underlying EBITDA

and underlying NPAT in relation to the six month period to 30 September 2021 by $1.8m and

reduces the underlying EBITDA and underlying NPAT position in relation to the six month period

to 30 September 2020 by $1.8m.

AT A GLANCE
Oceania is a leading provider of premium healthcare

services to older people in New Zealand. We are

dedicated to delivering exceptional and innovative

hospitality services that delight our residents and

lead the sector.

We have a substantial development pipeline with

545 units under construction across New Zealand.

Better experiences.

OCEANIAINTERIM REPORT 2022

04

As at 30 September 2021
Existing sites

with mature

operations

Existing sites

with brownfield

developments

Undeveloped

sites

Total sites

25201

46

2,800

2,652

4,000

1,509

Staff

Care beds and care suites

Residents

Units

(current and planned)

AT A GLANCE

05

OCEANIAINTERIM REPORT 2022
06

TRADING HIGHLIGHTS Six months to 30 September 2021

Operating Cash Flow

six months to 30 September 2021

Reported Total

Comprehensive Income

six months to 30 September 2021

higher than six months

to 30 November 2020

of $57.0m

compared to six months

to 30 November 2020

of $74.5m

$

52.5m

$

62.7m

Underlying Earnings Before

Interest, Tax, Depreciation

and Amortisation

six months to 30 September 2021

Total assets

as at 30 September 2021

higher than six months

to 30 September 2020

of $30.5m

19.7 %

$

2.1bn

$

36.5m

higher than 31 March 2021 of $1.9bn

9.7 %

Financial Six months to 30 September 2021

Delivering better.

10.5%

TRADING HIGHLIGHTS
07

Operational Six months to 30 September 2021

Developments Six months to 30 September 2021

230

New units

57

New care suites

44

Resale units

45

Resale care suites

84

ahead of total sales for the

six months to 30 September 2020

10.6%

Total sales

Units + care suites

40

Units + care suites

59

Consents securedCompleted

Resource consents received during

the six months to 30 September 2021

Units and care suites completed in the

six months to 30 September 2021 at:

Units + care suites

545

Under construction

Units and care suites under construction

as at 30 September 2021:

– Awatere Stage 2 (Hamilton)

– The BayView Stage 2B (Tauranga)

– Lady Allum Stage 1 (Milford)

– Waimarie Street (St Heliers, Auckland)

– Redwood (Blenheim)

– The Bellevue Stage 2 (Christchurch)

– Elmwood Stage 1 (Manurewa, Auckland)

– Gracelands (Hastings)

– Eden (Mt Eden, Auckland)

– Gracelands (Hastings)

– Stoke (Nelson)

Units + care suites

112

Further expected to complete in FY2022

Units and care suites expected to

complete in FY2022:

– The BayView Stage 2B (Tauranga)

– Awatere Stage 2 (Hamilton)

– Gracelands (Hastings)

Oceania has continued to deliver a safe,
vibrant and well connected community

for our residents despite the last six weeks

of the period being dominated by

Governmental restrictions and costs

associated with COVID-19. We thank

our team who have worked tirelessly

to deliver the very best quality of care

and resident experience.

Prior to the Alert Level Four lockdown

being announced on 17 August 2021,

sales volumes were strong and

development activities were progressing

well. The extended lockdowns, particularly

in the Auckland region, have temporarily

impacted Oceania’s sales, delayed

building works and added direct

costs associated with COVID-19.

Oceania’s continued focus on the

health and safety of its residents has

been recognised, with many residents

moving into Oceania’s independent living

apartments and villas once the Alert Level

Four lockdown restrictions were lifted

around the country, to take advantage

of the security and other benefits that

retirement living offer. In addition,

Oceania continued to take admissions to

its care centres (including to care suites)

throughout Alert Levels Four and Three.

This feature of Oceania’s aged care

business makes it more resilient to changes

in market conditions and property price

cycles, thereby reducing the impact of

uncertain future economic conditions on

the business.

Oceania supports the recent Government

announcement of the Public Health Order

for mandatory vaccinations for all frontline

healthcare staff, as this provides clarity

and certainty for our workforce both

today and in the future.

Dear Shareholder,

We are pleased to present our Interim Report


for the six month period to 30 September 2021.

08

OCEANIAINTERIM REPORT 2022

The key highlights for the first half of
FY2022 have included:

–A 19.7% increase ($6.0m) in unaudited

underlying EBITDA compared to the six

month period ended 30 September 2020.

–Unaudited Reported Net Profit After Tax

(NPAT) of $36.9m, up $12.1m on the six

month period ended 30 November 2020.

–Sales volumes (for both independent

living apartments and villas, as well as

care suites) being 10.6% ahead of the

six month period ended 30 September

2020, despite ongoing COVID-19

lockdown restrictions.

–Completion of the acquisition of

Waterford (Hobsonville Point, Auckland)

in April 2021 and a resource consent for

50 independent living apartments and

a basement carpark has been secured.

–The completion of 49 apartments

at Eden (Auckland) in April 2021 and

eight villas at Gracelands (Hastings)

in September 2021.

–545 units (apartments, villas and

care suites) under construction as

at 30 September 2021.

–Oceania's aged care business

continued to perform well throughout

the period despite COVID-19 disruptions,

with occupancy of 92.5% as at

30 September 2021.

–Entry into a conditional sale and

purchase agreement to acquire land

adjacent to our Franklin site.

–Appointment of Andrew Buckingham

as Group General Manager Property

and Development.

–Oceania’s total assets are now

$2.1b, representing 9.7% growth

since 31 March 2021.

–Completion of a heavily oversubscribed

retail bond offer in September 2021,

raising $100m.

–Interim dividend of 2.1 cents per

share (not imputed) announced

(30 November 2020: 1.3 cents). This will

have a record date of 6 December 2021

and will be paid on 20 December 2021.

The Dividend Reinvestment Plan will

apply to this dividend.

Financial Performance

Oceania’s unaudited underlying EBITDA

was $36.5m for the six month period ended

30 September 2021, representing a $6.0m

or 19.7% increase on the six month period

ended 30 September 2020. This result

was primarily due to growth in deferred

management fees across both village and

care segments as Oceania executes its

pipeline of premium developments.

Unaudited Reported Net Profit After Tax

increased 48.9% to $36.9m for the six

month period ended 30 September 2021.

This was supported by positive fair value

movements in Oceania’s investment

property portfolio as sell down of key

development sites takes place, as well

as growth in recurring care and village

segment revenue streams.

Oceania’s total assets are now $2.1b,

representing 9.7% growth since

31 March 2021.

Operating cashflow decreased 29.5% to

$52.5m as a result of increased wage costs

and timing of village settlements. As at 30

September 2021, Oceania had outstanding

bank loans and bonds of $350.8m, $16.8m

of cash and undrawn bank facilities of

$224.2m. This represents a gearing ratio

of 27.4% as at 30 September 2021.

Following its successful inaugural seven

year retail bond issue in October 2020,

Oceania completed another heavily

oversubscribed seven year retail bond

issue in September 2021, raising $100m.

This further funding strengthens Oceania’s

position to support future growth.

09

CHAIR AND CEO'S REPORT

The Directors have declared an
interim dividend of 2.1 cents per share

(not imputed) (30 November 2020:

1.3 cents). The record date for entitlement

is 6 December 2021 and the dividend

will be paid on 20 December 2021.

The dividend reinvestment plan for our

New Zealand and Australian shareholders

will apply to this dividend payment.

COVID-19 and continuing response

High vaccination rates of more than 90%

across our residents and staff have made

a fundamental difference to Oceania’s

response this year and processes have

been refined based on the learnings from

the 2020 lockdowns. During the nationwide

Level Four lockdown, management held

daily calls with Regional Operations and

Clinical Managers, and calls with all

staff three times a week, both to provide

guidance to staff and to provide an

opportunity for staff to give their

feedback to management.

Before the August 2021 lockdown,

Oceania had introduced voluntary saliva

surveillance testing, an innovation for the

sector, for staff at some higher risk sites

and this was rolled out further during the

lockdown. Over 6,000 saliva tests were

taken in the period 18 August 2021

to 30 September 2021, all of which

produced negative results.

At the height of the outbreak, Dr Hughes

and her team sourced additional vaccines

and established pop-up vaccination

centres to offer vaccinations to Oceania

staff members and their families.

This initiative was very well received

by staff and their families as these

vaccination centres were more accessible

and smaller in size than many of the

community vaccination centres. Over

320 vaccinations were given to staff

and family members at the six pop-up

vaccination centres in August and

September, with most of these being first

vaccinations. As part of this initiative, we

gave away cookies, chocolate brownies,

kit kat bars, hand sanitisers and goodie

bags to those being vaccinated, with

leftovers being included in food parcels

provided to those in need in our community.

Throughout the period, Oceania has been

working proactively and directly with

Government officials, Ministry of Health

representatives and sector peers with

regard to health policy. Small policy

changes have a significant effect on

businesses and management has been

successful in many of its discussions with

Government officials and Ministry of

Health representatives which has led to

improved outcomes for the sector and,

ultimately, for residents.

We have also taken an industry leadership

position in calling for our Auckland residents

to be allowed to reconnect with their loved

ones safely. This initiative struck a chord

with New Zealanders and was followed

with extensive media coverage including

numerous spots on talkback radio. We

received a lot of positive feedback from

residents and their family members, in

adding our voice to theirs, not just for

Oceania but for all older citizens.

In addition, management has

representation on the boards of both

the New Zealand Aged Care Association

and the Retirement Villages Association.

Both of these groups have been lobbying

the Government for clarity and certainty

in the current COVID-19 environment.

In recognition of our staff going the extra

mile, both for our residents and for each

other, Oceania paid a gratitude payment

to all staff throughout New Zealand of $150

(gross) for full-time staff and $75 (gross)

for part-time staff on 2 September 2021.

OCEANIAINTERIM REPORT 2022

10

This payment recognised the difficulties
and disruptions faced by all staff, and the

ongoing uncertainty which impacted

everyone. The payment was very well

received by our staff.

The duration of the lockdown restrictions

in Auckland has affected one of Oceania’s

key development projects, being the

construction of the new care centre at

Lady Allum (Milford, Auckland). This

development (comprising 113 care suites)

was expected to be completed by 31 March

2022 but with the ongoing lockdown

restrictions in place in Auckland, it is

now likely to be completed in May 2022.

Looking ahead, Oceania maintains good

levels of stock of PPE including N95 masks

and inventory is being recorded on a daily

basis. Oceania remains well-prepared to

manage any infections that occur at its

sites, with industry-leading infection

control policies and a highly experienced

clinical team.

Operations

We have continued to see aged care

earnings increase during the period.

Care suite sales have remained strong,

with a total of 44 new care suite sales

and 84 resale care suite sales in the

six month period to 30 September 2021.

This demonstrates the resilience of

Oceania’s care business and the

attractiveness of the care suite product

to prospective residents. It was also

pleasing to see occupancy of 92.5%

compared with 92.4% as at 31 March 2021.

Village sales have remained strong

throughout the period, despite ongoing

COVID-19 restrictions. In the six months

to 30 September 2021, there was a total

of 102 independent living (apartment

and villa) sales, comprising 57 new sales

and 45 resales. This is an increase of

25.9% from the six month period ended

30 September 2020. As noted above,

CHAIR AND CEO'S REPORT

11

there were strong sales volumes prior to the
Alert Level Four lockdown announcement

on 17 August 2021. Many of the new sales

were sales of the remaining units that

were completed in regional villages during

the prior financial years, including at

Whitianga, Woodlands and Elderslea.

During Alert Level Four, residents who

had already signed application forms

were generally not able to move into their

independent living apartments and villas

and our sales team were unable to show

prospective residents through our villages.

With the easing of lockdown restrictions,

we saw residents who had already signed

application forms and sold their houses

move in to their new apartments and

villas in September 2021.

Oceania is maintaining its focus on

improving and refining the resident

experience. We adopt a resident-centric

approach in everything that we do and are

constantly striving to deliver on our brand

promise to Believe in Better. We have made

an intentional change in strategic focus

from product to customer needs and

associated services and, with that, we are

designing our buildings with the needs of

the customers at a specific village in mind,

rather than the other way around. We are

also continuing our work with the

University of Auckland in robotics and

biomedics to develop leading initiatives

in resident-focused clinical care.

Sustainability

Oceania is continuing its work on

sustainability initiatives. We are in the

process of developing our roadmap in

relation to climate related disclosures

against the standards based on the TCFD

recommendations, details of which will be

incorporated into the FY2022 Annual

Report. In addition, given the recent

changes to the Board and management

team, Oceania’s ESG framework and

materiality matrix is being refreshed and

the outcomes of this will also be included

in the Annual Report.

Food service delivery is a key component

of Oceania’s aged care business and this

has been enhanced by the roll out of new

food service contracts across our sites

during the period. In addition to achieving

significant efficiencies and uniformity

across the group and ensuring that all

of our residents’ dietary requirements are

being met, this initiative has reduced the

number of vehicle deliveries to our sites

and has improved the overall sustainability

of this aspect of the supply chain.

People

Oceania’s people are at the very heart of

its business. We are focused on creating

and maintaining a great employee

experience and culture, to enable our

people to perform their life’s best work.

The aged care industry is facing a workforce

crisis, which has been exacerbated by the

impact of the COVID-19 border restrictions

on arrivals of registered nurses from

overseas. We have implemented a number

of initiatives to try to address the staff

shortages, including additional professional

development, improved employee benefits

and a review of remuneration levels.

In addition, we have recently rolled out

a new recruitment system, which is

designed to be linked to our brand promise

of Believe in Better. As part of this new

system, we have also introduced new

employment agreements, automatic

contract generation and online reference

checking to enhance the overall employee

experience. Feedback to date has been

very positive and we are excited about

embedding our brand promise through

our people systems.

OCEANIAINTERIM REPORT 2022

12

Oceania became a member of ACC’s
Accredited Employer Programme on

1 April 2021. We are already starting to

see the benefits of this, with better case

management, early prevention and a

significant reduction in the number of

lost time injuries compared to the prior

corresponding period.

We are pleased to announce the

appointment of Andrew Buckingham

as Group General Manager Property

and Development.

Andrew has extensive senior executive

experience in property development after

CHAIR AND CEO'S REPORT

13

over 35 years working for leading property

development companies in New Zealand

and Australia. Previously the General

Manager of Development at Precinct

Properties, Andrew was responsible

for the delivery of Commercial Bay in

Auckland. Andrew was also responsible

for the ASB North Wharf development

and the development of the Sylvia Park

retail complex during his tenure at Kiwi

Income Property Trust. We are looking

forward to Andrew starting at Oceania

in February 2022.

1414
OCEANIAINTERIM REPORT 2022

Developments

We have continued to make good progress

with the execution of our development

pipeline during the six month period to

30 September 2021, despite the challenges

presented by the COVID-19 lockdown

restrictions. As at 30 September 2021,

there were 545 units under construction

across New Zealand.

Oceania completed the acquisition of

Waterford, in Hobsonville Point (Auckland)

in April 2021. Since taking ownership in

April 2021, Oceania has secured resource

consent for the development of 50

independent living apartments over five

storeys and a basement carpark on the

site. Work has commenced on the design

elements required for the building consent

for this development and, at this stage,

it is likely that construction will commence

in April 2022.

We completed the construction of 49

apartments and a new community centre at

Eden Village (Auckland) in April 2021. With

the completion of these new apartments,

the village now comprises 67 care suites

and 89 independent living apartments as

well as outstanding community spaces.

We were seeing good levels of interest in the

independent living apartments prior to the

Alert Level Four restrictions being imposed

in August 2021 and are implementing new

sales initiatives at Eden Village for the

second half of FY2022.

We also completed eight new villas in

September 2021 and ten new villas in

October 2021 at Gracelands (Hastings).

Most of these new villas were presold, with

residents taking occupation of seven new

villas by 30 September 2021. The high level

of presales at Gracelands demonstrates

the strength of Oceania’s regional offering

and the successful development of units

that meet the specific needs of the

particular community in which the village

is located.

Awatere, Hamilton

14

1515
CHAIR AND CEO'S REPORT

Construction of Stage 2B of The BayView

(Tauranga) comprising 39 independent

living apartments is scheduled for

completion in December 2021. 35

independent living apartments were

completed at The BayView in March 2021

and we have already seen strong sales

from this premium development.

Construction of 63 new independent

living apartments at Awatere (Hamilton)

is progressing well and this stage of

development is currently expected to be

completed by 31 March 2022, provided

there are no further material delays as a

result of COVID-19 lockdown restrictions.

Marketing for these apartments has

already commenced and we have seen

good levels of interest in these apartments

to date.

Other development projects are also

underway and remain on programme,

including the development of 79

independent living apartments and

31 care suites at Waimarie Street

(St Heliers, Auckland), the construction

of 57 new care suites at Redwood

(Blenheim) and the construction of

46 new independent living apartments

at The Bellevue (Christchurch). We have

also just started the site works for the

first stage of the redevelopment of our

Elmwood site (Manurewa, Auckland),

which comprises the construction of

106 new care suites on land that we

acquired in 2018.

Governance

We welcomed two new independent

Directors, Rob Hamilton and Peter Dufaur,

to the Board in September 2021. Rob has

extensive experience in the capital markets

and finance sectors and has been appointed

a member of our Audit Committee. Peter

has extensive experience in the property

sector and has been appointed a member

of our Development Committee. We are

looking forward to Rob and Peter making

a significant contribution to the future

performance and growth of Oceania.

Looking ahead

Oceania has entered into an exclusive

partnership with the Bay of Plenty District

Health Board to explore and develop a

new service model for high needs and

complex aged care residents. We are

looking forward to working with this

District Health Board to enhance services

for this group of residents.

We will continue to pursue growth

opportunities, including the purchase

of additional land. We recently entered

into a conditional sale and purchase

agreement to acquire land adjacent to

our Franklin site.

Once again, we would like to thank our

Directors and staff for their ongoing work

in what has been another challenging

period due to the ongoing uncertainties

associated with COVID-19. To date

Oceania has managed these risks well

and is well-placed to continue to do so.

We are committed to becoming the

provider of choice for critical infrastructure

and essential services for older people in

New Zealand.

Brent Pattison

Chief Executive Officer

Elizabeth Coutts

Chair

15

16
OCEANIAINTERIM REPORT 2022

1717
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

THREE YEAR SUMMARY

For the six months ended 30 September 2021

Financial Metrics

$NZm

Unaudited

Sept 2021

Unaudited

Nov 2020

Unaudited

Nov 2019

Underlying net profit after tax

1, 2, 3, 4

27.526.924.3

Underlying EBITDA

1, 3, 4


36.535.337.1

Profit / (loss) for the period

4

36.924.814.4

Total comprehensive income

62.757.023.5

Total assets

4

2,064.31,672.21,495.3

Operating cash flow

4

52.574.556.5

Operating Metrics

$NZm

Unaudited

Sept 2021

Unaudited

Nov 2020

Unaudited

Nov 2019

Units

1,5091,3101,209

Care Suites

849772655

Care Beds

1,8031,8301,940

Total

4,1613,9123,804

New Sales

10114584

Resales

129123102

Total

230268186

Occupancy

92.5%92.1%91.6%

1

This is a non-GAAP measure, refer to note 2.1 in the consolidated interim financial statements

for further details.

2

Underlying Net Profit after Tax has been restated in comparative periods to exclude depreciation

in respect of care suites in line with the current period.

3

On 21 April 2020 the Group claimed, and received payment of, a COVID-19 wage subsidy totalling

$1.8m. This amount has subsequently been repaid in full on 18 May 2021 and as a result has

been excluded from the table above. This proforma adjustment increases underlying EBITDA and

underlying NPAT in relation to the six month period to 30 September 2021 by $1.8m. The six month

period to 30 November 2020 is not impacted by this proforma adjustment.

4

Includes an adjustment for the impact in change in accounting policy in regards to the accounting

for Software as a Service arrangements. Refer to note 1.2.

CONSOLIDATED
INTERIM FINANCIAL

STATEMENTS

For the six months ended 30 September 2021

Consolidated Statement of Comprehensive Income 19

Consolidated Balance Sheet 20

Consolidated Statement of Changes in Equity 21

Consolidated Cash Flow Statement 22

Notes to the Consolidated Interim Financial Statements 23

Independent Auditor's Review Report 67

1818

OCEANIAINTERIM REPORT 2022

1919
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 September 2021

$NZ000’s Notes

Unaudited

Six months

30 Sept 2021

Unaudited

Six months

30 Nov 2020

Revenue

113,935103,885

Change in fair value of investment property

3.1

31,29926,651

Change in fair value of right of use investment property

3.4

9862,276

Gain on purchase of business assets

1.3

8,538-

Other income

1,2231,145

Total income

155,981133,957

Employee benefits and other staff costs

1

77,00268,370

Depreciation (buildings)

3.2, 3.4

6,3375,049

Depreciation and amortisation (chattels, leasehold

improvements and software)

1

3.2, 3.4

3,5292,894

Impairment of property, plant and equipment and right

of use asset

3.2

193517

Impairment of goodwill

338815

Rental expenditure in relation to right of use investment

property

3.41,9283,330

Finance costs

4,1214,011

Other expenses

1, 2

29,07728,597

Total expenses

1

122,525113,583

Profit before income tax

1


33,45620,374

Income tax benefit

5.1

3,4844,436

Profit for the period

1

36,94024,810

Other comprehensive income

Items that will not be subsequently reclassified to profit or loss

Gain on revaluation of property, plant and equipment for

the period, net of tax

3.2, 5.122,48831,231

Gain on revaluation of right of use assets for the period,

net of tax

3.4, 5.111927

22,60731,258

Items that may be subsequently reclassified to profit or loss

Gain on cash flow hedges, net of tax

3,108918

Other comprehensive income for the period, net of tax

25,71532,176

Total comprehensive income for the period attributable to

shareholders of the parent

1

62,65556,986

Basic earnings per share (cents per share)

4.2

5.34.0

Diluted earnings per share (cents per share)

4.2

5.34.0

The above Consolidated Statement of Comprehensive Income should be read in conjunction with the

accompanying notes.

1

Comparatives have been restated for the impact of a change in accounting policy in regards

to the accounting for Software as a Service arrangements. Refer to note 1.2.

2

Included in Other Expenses for the six months to 30 September 2021 is a payment of $1.8m

in respect to the wage subsidy.

2020
OCEANIAINTERIM REPORT 2022

CONSOLIDATED BALANCE SHEET

As at 30 September 2021

1

Comparatives have been restated for the impact of a change in accounting policy in regards

to the accounting for Software as a Service arrangements. Refer to note 1.2.

$NZ000’s NotesUnaudited

30 Sept 2021

Audited

31 Mar 2021

Assets

Cash and cash equivalents

16,79679,906

Trade and other receivables

1

57,49647,992

Investment property

3.1

1,294,7551,099,803

Property, plant and equipment

3.2

645,079604,052

Right of use assets

3.4

41,14441,714

Intangible assets

1

9,0558,689

Total assets

1

2,064,3251,882,156

Liabilities

Trade and other payables

33,84144,308

Derivative financial instruments

1,4875,486

Deferred management fee

3.3

46,03341,499

Refundable occupation right agreements

3.3

716,539618,433

Lease liabilities

3.4

8,77611,513

Borrowings

4.3

350,729327,292

Deferred tax liabilities

5.1

--

Total liabilities

1,157,4051,048,531

Net assets

1

906,920833,625

Equity

Contributed equity

4.1

700,717675,625

Retained deficit

1

(64,495)(86,983)

Reserves

270,698244,983

Total equity

1

906,920833,625

The above Consolidated Balance Sheet should be read in conjunction with the accompanying notes.

2121
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 30 September 2021

1

Comparatives have been restated for the impact of a change in accounting policy in regards

to the accounting for Software as a Service arrangements. Refer to note 1.2.

$NZ000’s NotesContributed

equity

Retained

deficit

Asset

revaluation

reserve

Cash

flow

hedge

reserve

Total

equity

Balance as at 1 June 2020 (audited)

1

588,389(157,630)170,205(7,475)593,489

Profit for the period

1

- 24,488 - -24,488

Other comprehensive income

Revaluation of cash flow hedge net of tax

---918918

Revaluation of assets net of tax

3.2, 5.1

- -31,231-31,231

Revaluation of right of use

assets net of tax

3.4, 5.1

- -27-27

Total comprehensive income

1

- 24,48831,25891856,664

Transactions with owners

Dividends paid

4.1

-(7,377)--(7,377)

Share issue: dividend

reinvestment scheme

4.1

7,028---7,028

Employee share scheme

4.1

-307--307

Total transactions with owners

7,028(7,070) - -(42)

Balance as at 30 November 2020

(unaudited)

1

595,417(140,212)201,463(6,557)650,111

Balance as at 1 April 2021 (audited)

675,625(86,983)248,849(3,866)833,625

Profit for the period

-36,940--36,940

Other comprehensive income

Revaluation of cash flow hedge net of tax

---3,1083,108

Revaluation of assets net of tax

3.2, 5.1

--22,488-22,488

Revaluation of right of use

assets net of tax

3.4, 5.1

--119-119

Total comprehensive income

-36,94022,6073,10862,655

Transactions with owners

Dividends paid

4.1

-(14,730)-- (14,730)

Share issue

4.1

20,000---20,000

Directly attributable

transaction costs deducted

from equity

4.1

(475)---(475)

Share issue: dividend

reinvestment scheme

4.1

5,567---5,567

Employee share scheme

4.1

-278--278

Total transactions with owners

25,092(14,452)--10,640

Balance as at 30 September 2021

(unaudited)

700,717(64,495)271,456(758)906,920

The above Consolidated Statement of Changes in Equity should be read in conjunction with the

accompanying notes.

2222
1

22

OCEANIAINTERIM REPORT 2022

CONSOLIDATED CASH FLOW STATEMENT

For the six months ended 30 September 2021

$NZ000’s

Unaudited

Six Months

30 Sept 2021

Unaudited

Six months

30 Nov 2020

Cash flows from operating activities

Receipts from residents for village and care fees

97,04382,829

Payments to suppliers and employees

1

(113,058)(84,378)

Rental payments in relation to right of use investment property

(1,928)(3,330)

Receipts from new occupation right agreements

109,323113,436

Payments for outgoing occupation right agreements

(35,664)(29,882)

Interest received

2118

Interest paid

(2,986)(3,711)

Interest paid in relation to right of use assets

(301)(463)

Net cash inflow from operating activities

1

52,45074,519

Cash flows from investing activities

Proceeds from sale and / or disposal of property, plant and

equipment and investment property

--

Payments for property, plant and equipment and intangible assets

1

(25,238)(20,871)

Payments for investment property and investment property

under development

(61,031)(39,152)

Payments for business assets(56,208)-

Net cash outflow from investing activities

1

(142,477)(60,023)

Cash flows from financing activities

Proceeds from borrowings

70,88048,369

Repayment of borrowings

(51,686)(60,646)

Proceeds from bond issuance

100,000125,000

Repayment of bank borrowing from bond proceeds

(100,000)(125,000)

Proceeds from share placement

20,000-

Capitalised costs in relation to share placement

(475)-

Capitalised borrowing costs

(1,194)(1,861)

Principal payments for right of use assets

(1,445)(1,264)

Dividends paid

(9,163)(349)

Net cash inflow from financing activities

26,917(15,751)

Net decrease in cash and cash equivalents

(63,110)(1,255)

Cash and cash equivalents at the beginning of the period

79,90617,624

Cash and cash equivalents at end of period16,79616,369

The Board of Directors of the Company authorised these Consolidated Interim Financial

Statements for issue on 29 November 2021.

For and on behalf of the Board

Elizabeth Coutts Alan Isaac

Chair Director

The above Consolidated Cash Flow Statement should be read in conjunction with the accompanying notes.

1

Comparatives have been restated for the impact of a change in accounting policy in regards

to the accounting for Software as a Service arrangements. Refer to note 1.2.

2323
1

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

NOTES TO THE CONSOLIDATED

INTERIM FINANCIAL STATEMENTS

For the six months ended 30 September 2021

1. General Information 24

1.1 Basis of Preparation 24

1.2 Accounting Policies 26

1.3 Significant Events and Transactions 27

2. Operating Performance 31

2.1 Operating Segments 31


3. Property Assets 41

3.1 Village Assets: Investment Property 43

3.2 Care Assets: Property, Plant

and Equipment 47

3.3 Refundable Occupation

Right Agreements 50

3.4 Leases 52

4. Shareholder Equity and Funding 55

4.1 Shareholder Equity and Reserves 55

4.2 Earnings per Share 58

4.3 Borrowings 59

5. Other Disclosures 62

5.1 Income Tax 62

5.2 Contingencies and Commitments 66

5.3 Events After Balance Date 66

Independent Auditor's Review Report 67

23

24
NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

ffCONTINUEDfi

For the six months ended 30 September 2021

24

OCEANIAINTERIM REPORT 2022

1. General Information

1.1 Basis of Preparation

(i) Entities Reporting

The consolidated interim financial statements of the Group are for the economic

entity comprising Oceania Healthcare Limited (the “Company”) and its subsidiaries

(together “the Group”). Refer to note 5.5 of the 31 March 2021 annual report for

details of the Group structure.

The consolidated interim financial statements incorporate the assets and liabilities

of all subsidiaries of Oceania Healthcare Limited as at 30 September 2021 and the

results of all subsidiaries for the six months then ended.

The Group owns and operates various care centres and retirement villages

throughout New Zealand. Post balance date the Group Support Office functions

were relocated to new premises. The Group's registered office is Level 11, 80 Queen

Street, Auckland 1010, New Zealand (31 March 2021: 2 Hargreaves Street, St Marys

Bay, Auckland 1011).

(ii) Statutory Base

Oceania Healthcare Limited is a limited liability company which is domiciled and

incorporated in New Zealand. It is registered under the Companies Act 1993 and

is a FMC Reporting Entity in terms of Part 7 of the Financial Markets Conduct Act

2013. The Company is also listed on the NZX Main Board (“NZX”) and the Australian

Securities Exchange (“ASX”) as a foreign exempt listing. The consolidated interim

financial statements have been prepared in accordance with the requirements of

the NZX and ASX listing rules, and Part 7 of the Financial Markets Conduct Act 2013.

The consolidated interim financial statements have been prepared in accordance

with New Zealand Generally Accepted Accounting Practice (“NZ GAAP”). They

comply with New Zealand Equivalent to International Accounting Standard 34

Interim Financial Reporting (“NZ IAS 34”) and International Accounting Standard 34

Interim Financial Reporting (“IAS 34”). The Group is a Tier 1 for-profit entity in

accordance with XRB A1.

The accounting policies that materially affect the measurement of the Consolidated

Statement of Comprehensive Income, Consolidated Balance Sheet and the

Consolidated Cash Flow Statement have been applied on a basis consistent with

those used in the audited consolidated financial statements for the year ended

31 March 2021.

The consolidated interim financial statements do not include all the notes of

the type normally included in the consolidated annual financial statements.

Accordingly, these consolidated interim financial statements are to be read

in conjunction with the consolidated annual financial statements for the year

ended 31 March 2021, prepared in accordance with New Zealand Equivalents

to International Financial Reporting Standards (“NZ IFRS”).

2525
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

The consolidated interim financial statements for the six months ended

30 September 2021 and comparatives for the six months ended 30 November 2020

are unaudited. The consolidated annual financial statements for the year ended

31 March 2021 were audited and form the basis for the comparative figures for that

period in these statements. They are presented in New Zealand dollars which is the

Group’s presentation currency.

The consolidated interim financial statements have been prepared in accordance

with the going concern basis of accounting, which assumes that the Group will be

able to realise its assets and discharge its liabilities in the normal course of business

as they come due into the foreseeable future.

The Consolidated Balance Sheet has been prepared using a liquidity format.

(iii) Measurement Basis

These consolidated interim financial statements have been prepared under the

historical cost convention, as modified by the revaluation of certain assets and

liabilities, including investment properties, certain classes of property, plant and

equipment, right of use assets, assets held for sale and cash flow hedges.

(iv) Key Estimates and Judgements

The preparation of the consolidated interim financial statements in conformity

with NZ IFRS requires the use of certain critical accounting estimates. It also requires

management to exercise their judgement in the process of applying the Group’s

accounting policies.

The Group makes estimates and assumptions concerning the future. The resulting

accounting estimates will, by definition, seldom equal the related actual results.

Estimates and judgements are continually evaluated and are based on historical

experience and other factors, including expectations of future events that are

believed to be reasonable under the circumstances.

The areas involving a higher degree of judgement or complexity, or areas where

assumptions and estimates are significant to the consolidated financial statements

are disclosed in the following notes:

– Fair value of business combination (note 1.3)

– Classification of accommodation with a care or service offering (note 3)

– Fair value of investment property and investment property under development

(note 3.1)

– Fair value of freehold land and buildings (note 3.2)

– Revenue recognition of deferred management fees (note 3.3)

– Fair value of right of use assets (note 3.4)

– Recognition of deferred tax (note 5.1)

26
NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

ffCONTINUEDfi

For the six months ended 30 September 2021

26

OCEANIAINTERIM REPORT 2022

1.2 Accounting Policies

(i) New Accounting Standards

During the period, the Group revised its accounting policy in relation to upfront

configuration and customisation costs incurred in implementing Software as a

Service (‘SaaS’) arrangements. This was in response to the IFRIC agenda decision

in April 2021 clarifying its interpretation of how current accounting standards apply

to these types of arrangements. The new accounting policy is presented below.

No other changes to accounting policies have been made during the period and

the Group has not early adopted any standards, amendments or interpretations

to existing standards that are not yet effective.

Software as a Service (“SaaS”) arrangements

SaaS arrangements are service contracts providing the Group with the right to

access the cloud provider’s application software over the contract period but

where the Group does not control the underlying software used in the arrangement.

Under the new accounting policy, where costs incurred to configure or customise

SaaS arrangements result in the creation of a resource which is identifiable, and

where the Group has the power to obtain the future economic benefits flowing from

the underlying resource and to restrict the access of others to those benefits, such

costs are recognised as a separate intangible software asset and amortised over

the useful life of the software on a straight-line basis. If costs do not meet the

recognition criteria, they are expensed when incurred. The useful lives of the

intangible assets are reviewed at least at the end of each financial year, and any

change accounted for prospectively as a change in accounting estimate.

During the period the Group reviewed the agreements supporting documentation

for all capitalised software and associated projects. In light of guidance from the

IFRIC agenda decision, one item of software which was procured during the year

ended 31 May 2020 no longer met the criteria for capitalisation. The Group has

applied the required treatment retrospectively and the effect of this change in

treatment is shown below.

Comparative information has been restated to reflect the retrospective application

of SaaS guidance with respect to one item of software held by the Group which

was purchased in 2017.

The impact of this to the six months to 30 November 2020 profit and loss is a net

increase to Net Profit after Tax of $26k comprising:

– a decrease to amortisation, recognised in depreciation and amortisation

(chattels, leasehold improvements and software), of $131k;

– an increase in staff costs, recognised in employee benefits and other staff costs,

of $59k; and

– an increase to IT costs, recognised in other expenses, of $46k.

A net decrease to Net Assets as at 31 March 2021 of $1.6m comprises a decrease

in intangible assets of $1.9m and an increase in prepayments, recognised in trade

and other receivables, of $0.3m. The opening retained deficit increased by $1.5m.

2727
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

The balance of the impact to Net Profit after Tax was incurred in the periods from

November 2017 to 31 May 2020. The total impact on Net Profit after Tax comprised

a decrease to amortisation of $0.3m offset by an increase in staff costs of $1.2m

and an increase to IT costs of $0.7m.

(ii) Measurement of Fair Value

The Group classifies its fair value measurement using the fair value hierarchy

that reflects the significance of the inputs used in making the measurements.

The fair value hierarchy has the following levels.

Level 1: Quoted prices (unadjusted) in active markets for the identical assets

or liabilities.

Level 2: Inputs other than quoted prices included within Level 1 that are observable

for the asset or liability, either directly (i.e. as prices) or indirectly

(i.e. derived from prices).

Level 3: Inputs for the asset or liability that are not based on observable market

data (unobservable inputs).

The carrying amount of all financial assets and liabilities is considered to

approximate their fair value.

1.3 Significant Events and Transactions

(i) COVID-19

On 11 March 2020, the World Health Organisation declared COVID-19 to be a global

pandemic. COVID-19 has impacted the health and wellbeing of people around the

world and in turn the outbreak and the associated restrictions put in place to fight

the virus have had a significant adverse impact on the global economy.

The New Zealand Government’s overall public health strategy in respect of the

COVID-19 pandemic affecting New Zealand was elimination with the overall goal to

stop community transmission in New Zealand. Refer to note 1.3 of the 31 March 2021

Annual Report for specific details of events to 31 March 2021.

– New Zealand was in Alert Level 1 at the time of signing the 31 March 2021

Annual Report.

– At 11:59pm on 17 August 2021 all of New Zealand entered Alert Level 4.

– At 11.59pm on 31 August 2021 all of New Zealand with the exception of the greater

Auckland region and Northland entered Alert Level 3. The greater Auckland region

and Northland remained at Alert Level 4.

– At 11.59pm on 1 September 2021 Northland entered Alert Level 3 with no alert level

changes in other areas.

– At 11.59pm on 7 September 2021 Alert Level 2 came into force for all regions except

the greater Auckland region which remained at Alert Level 4.

– At 11.59pm on 21 September 2021 Alert Level 3 came into force for the greater

Auckland region and Upper Hauraki.

28
NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

ffCONTINUEDfi

For the six months ended 30 September 2021

28

OCEANIAINTERIM REPORT 2022

1.3 Significant Events and Transactions (continued)

– At 11.59pm on 25 September 2021 Upper Hauraki moved to Alert Level 2.

– At 11.59pm on 3 October 2021 Alert Level 3 came into force for Raglan,

Te Kauwhata, Huntly, Ngaruawahia, Hamilton City and some surrounding areas.

– At 11.59pm on 5 October 2021 Alert Level 3 restrictions eased for the greater

Auckland region and it entered Alert Level 3 Step 1.

– At 11.59pm on 7 October 2021 the Waikato Alert Level 3 boundary was extended to

include Waitomo District, including Te Kuiti, Waipa District and Otorohanga District.

– At 11.59pm on 8 October 2021 Alert Level 3 came into force for Northland.

– At 11.59pm on 19 October 2021 Northland moved to Alert Level 2.

– At 11.59pm on 27 October 2021 Alert Level 3 restrictions eased and the parts of

the Waikato at Alert Level 3 moved to step 1 of Alert Level 3.

– At 11.59pm on 2 November 2021 parts of Waikato moved to Alert Level 3 step 2,

and Upper Northland moved to Alert Level 3.

– At 11.59pm on 9 November 2021 Auckland moved to Alert Level 3 step 2.

– At 11.59pm on 11 November 2021 Upper Northland moved to Alert Level 2.

– At 11.59pm on 16 November 2021 parts of Waikato moved to Alert Level 2.

Certain key judgements and estimates are applied in the consolidated

interim financial statements.

The Directors have assessed the impact of COVID-19 on these judgements and

estimates and concluded that no changes are necessary. This is primarily due

to Oceania providing an essential service. The following key matters were

considered and undertaken with regards to the financial impact of COVID-19

on the 30 September 2021 consolidated interim financial statements:

– CBRE Limited as independent valuers undertook a valuation as at 30 September

2021. CBRE Limited at 30 September 2021 note in their report that, given the

ongoing uncertainty and unknown impact that COVID-19 might have on real

estate markets in the future, a degree of caution should be exercised when relying

upon the valuation. Values and incomes may change more rapidly and significantly

than during standard market conditions. To this end CBRE Limited recommend that

their valuation is reviewed periodically over the coming months.

– No changes to the methodology or input estimates in relation to expected credit

losses have been required as a result of continued strong collection levels in

respect of private care fees and deferred settlement of Occupation Right

Agreement (“ORA”) contracts.

2929
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(ii) Acquisition: Waterford on Hobsonville Point (“Waterford”)

On 23 March 2021, Oceania Village Company Limited entered into a Sale and

Purchase Agreement to purchase the business assets of Waterford on Hobsonville

Point. Waterford is an established retirement village with 64 independent living

villas and 36 independent living apartments. The Sale and Purchase Agreement

was conditional on the parties obtaining Statutory Supervisor consent. This consent

was received on 8 April 2021 and the transaction was settled on 23 April 2021.

The business assets have been recognised as at the date of settlement and the

future operating results consolidated from that point forward. The financial effects

of this transaction have been recognised in these interim financial statements.

Purchase consideration and fair value of net assets acquired

The purchase price of $56.2m was linked to the 31 March 2020 CBRE Limited

valuation of Waterford. The acquisition was accounted for using the acquisition

method as prescribed in NZ IFRS 3 Business Combinations. This standard requires

that all identifiable assets and liabilities be assumed at their acquisition date

fair value.

$NZ000’s

Fair value on

acquisition

Assets

Investment Property

105,662

Development Land

8,950

Chattels

63

Liabilities

Resident liabilities

(48,077)

Employee entitlements

(19)

Net Assets Acquired

66,579

Total Consideration

56,221

Deferred Tax on Acquisition

(1,820)

Gain on purchase of business assets

8,538


The gain on acquisition is due to the difference in the key assumptions within

CBRE Limited’s valuations, including growth rate and discount rate, between

31 March 2020, being the reference date for the acquisition, and 23 April 2021

being the settlement date, largely reflecting a reversal of COVID-19 impacts.

The impact of the acquisition on the operating results and underlying earnings

of the Group for the six months ended 30 September 2021 are not material.

The impact of the acquisition on the fair value movements in the period

is disclosed in note 3.1.

30
NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

ffCONTINUEDfi

For the six months ended 30 September 2021

30

OCEANIAINTERIM REPORT 2022

1.3 Significant Events and Transactions (continued)

Contingent liabilities

No material contingent liabilities with respect to this transaction were noted during

the due diligence process or since acquisition. Should any future contingent

liabilities arise, they will be disclosed in future financial statements.

(iii) Balance Date

On 9 July 2020 the Group received approval from the Commissioner of Inland

Revenue to change the balance date for the Group to 31 March. These consolidated

interim financial statements are the first adopting a 30 September interim balance

date. Both this period and the comparatives represent a period of six months.

(iv) Capital Raise

On 16 April 2021, a total of 15,619,810 ordinary shares ($20.0m, $1.2796 per share)

were issued in relation to the Retail Offer announced on 24 March 2021. These

shares rank equally in all aspects with existing shares.

(v) Retail Bond

On 30 August 2021 Oceania Healthcare Limited announced an offer of up to $75m

(with the ability to accept up to an additional $25m in oversubscriptions) of 7 year

secured fixed rate bonds. On 13 September 2021 bonds totalling $100.0m were

issued to New Zealand retail investors. These bonds mature on 13 September 2028.

A fixed interest rate of 3.3% per annum applies to the Bonds. Refer to note 4.3 for

the impact on the six months to 30 September 2021.

3131
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

2. Operating Performance

2.1 Operating Segments

The Group's chief operating decision maker is the Board of Directors.

The operating segments have been determined based on the information reviewed

by the Board of Directors for the purposes of allocating resources and assessing

performance. The assets and liabilities of the Group are reported to the chief

operating decision maker in total not by operating segment.

The Group operates in New Zealand and comprises three segments; care

operations, village operations and other.

Information regarding the operations of each reportable segment is included above.

Amongst other criteria, performance is measured based on segmental underlying

earnings before interest, tax, depreciation and amortisation (“EBITDA”), which is the

most relevant measure in evaluating the performance of segments relative to other

entities that operate within the aged care and retirement village industries.

Additional segmental reporting information

Capital expenditure: Refer to notes 3.1, 3.2 and 3.4 for details on capital

expenditure.

Goodwill: Goodwill is allocated to care cash generating units.

What is Total Comprehensive Income?

Total comprehensive income is a measure of the total performance of all

segments under NZ GAAP. It includes fair value movements relating to the

Group’s care centres and cash flow hedges.

32
NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

ffCONTINUEDfi

For the six months ended 30 September 2021

32

OCEANIAINTERIM REPORT 2022

CareVillageOther

ProductIncludes traditional care beds and care suites.Includes independent living and rental

properties.

N/A

ServicesThe provision of accommodation, care and

related services to Oceania’s aged care

residents.

Includes the provision of services such as

meals and care packages to independent

living residents.

The provision of accommodation and

related services to independent residents

in the Group’s retirement villages.

Provision of support services to the Group

(includes administration, marketing and

operations).

In addition this segment includes the

provision of training by the Wesley Institute

of Learning.

Recognition of Operating

Revenue and Expenses

The Group derives Operating Revenue from the

provision of care and accommodation. The daily

fee is set annually by the Ministry of Health.

In relation to the provision of superior

accommodation above the Government

specification the Group derives revenue from

Premium Accommodation Charges (“PACs”) or,

in the case of care suites, through Deferred

Management Fees (“DMF”).

Operating Expenses primarily include staff

costs, resident welfare expenses and overheads.

The Group derives Operating Revenue

from weekly service fees and rental income.

Operating Revenue also includes DMF

accrued over the expected occupancy

period for the relevant accommodation.

Operating Expenses include village property

maintenance, sales and marketing, and

administration related expenses.

Includes support office and corporate

expenses and rental costs relating to the

Group’s two leasehold sites.

Finance costs relate to the cost of bank debt

acquired for the purchase and development

of villages.

Income and expenditure relating to the

Wesley Institute of Learning is recognised

in this segment.

Recognition of Fair Value

movements on New

Developments

Fair value increases or decreases are recognised

in other comprehensive income (i.e. not in profit

or loss) for the fair value movement above

historical cost.

Impairments below historical cost are recognised

in comprehensive income (i.e. profit or loss).

Fair value movements are recognised in

comprehensive income (i.e. profit or loss).

N/A

Recognition of Fair Value

movements on Existing

Care Centres and

Retirement Villages

Fair value movements are treated the same

as above.

When sites are decommissioned for development

this results in an impairment of the buildings and

chattels which is recognised in comprehensive

income (i.e. profit or loss).

Fair value movements are recognised in

comprehensive income (i.e. profit or loss).

N/A

Recognition in Underlying

Profit (refer note 2.1 overleaf)

Fair value movements are removed.Fair value movements are removed. Realised

gains on resales and the development

margins from the sale of independent living

units and care suites are included, reflective

of the ownership structure of the assets.

No material adjustments.

Asset CategorisationAssets used, or, in the case of developments, to

be used, in the provision of care are recognised

as property, plant and equipment.

Assets used for village operations are

recognised as investment property.

Support office assets are recognised as

property, plant and equipment. Assets

include intangibles (e.g. software).

2.1 Operating Segments (continued)

3333
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

CareVillageOther

ProductIncludes traditional care beds and care suites.Includes independent living and rental

properties.

N/A

ServicesThe provision of accommodation, care and

related services to Oceania’s aged care

residents.

Includes the provision of services such as

meals and care packages to independent

living residents.

The provision of accommodation and

related services to independent residents

in the Group’s retirement villages.

Provision of support services to the Group

(includes administration, marketing and

operations).

In addition this segment includes the

provision of training by the Wesley Institute

of Learning.

Recognition of Operating

Revenue and Expenses

The Group derives Operating Revenue from the

provision of care and accommodation. The daily

fee is set annually by the Ministry of Health.

In relation to the provision of superior

accommodation above the Government

specification the Group derives revenue from

Premium Accommodation Charges (“PACs”) or,

in the case of care suites, through Deferred

Management Fees (“DMF”).

Operating Expenses primarily include staff

costs, resident welfare expenses and overheads.

The Group derives Operating Revenue

from weekly service fees and rental income.

Operating Revenue also includes DMF

accrued over the expected occupancy

period for the relevant accommodation.

Operating Expenses include village property

maintenance, sales and marketing, and

administration related expenses.

Includes support office and corporate

expenses and rental costs relating to the

Group’s two leasehold sites.

Finance costs relate to the cost of bank debt

acquired for the purchase and development

of villages.

Income and expenditure relating to the

Wesley Institute of Learning is recognised

in this segment.

Recognition of Fair Value

movements on New

Developments

Fair value increases or decreases are recognised

in other comprehensive income (i.e. not in profit

or loss) for the fair value movement above

historical cost.

Impairments below historical cost are recognised

in comprehensive income (i.e. profit or loss).

Fair value movements are recognised in

comprehensive income (i.e. profit or loss).

N/A

Recognition of Fair Value

movements on Existing

Care Centres and

Retirement Villages

Fair value movements are treated the same

as above.

When sites are decommissioned for development

this results in an impairment of the buildings and

chattels which is recognised in comprehensive

income (i.e. profit or loss).

Fair value movements are recognised in

comprehensive income (i.e. profit or loss).

N/A

Recognition in Underlying

Profit (refer note 2.1 overleaf)

Fair value movements are removed.Fair value movements are removed. Realised

gains on resales and the development

margins from the sale of independent living

units and care suites are included, reflective

of the ownership structure of the assets.

No material adjustments.

Asset CategorisationAssets used, or, in the case of developments, to

be used, in the provision of care are recognised

as property, plant and equipment.

Assets used for village operations are

recognised as investment property.

Support office assets are recognised as

property, plant and equipment. Assets

include intangibles (e.g. software).

34
NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

ffCONTINUEDfi

For the six months ended 30 September 2021

34

OCEANIAINTERIM REPORT 2022

2.1 Operating Segments (continued)

Six months ended 30 September 2021

(unaudited)

$NZ000’s

Care

Operations

Village

Operations

OtherTotal

Revenue

93,34119,733861113,935

Change in fair value of

investment property

-31,299-31,299

Change in fair value of right

of use investment property

-986-986

Gain on purchase of business assets

-8,538-8,538

Other income

147982731,202

Total income

93,48861,538934155,960

Operating expenses

(84,264)(11,195)(12,548)(108,007)

Impairment of goodwill

(338)--(338)

Impairment of property, plant

and equipment

(193)--(193)

Segment EBITDA

8,69350,343(11,614)47,422

Interest income

-31821

Finance costs

--(4,121)(4,121)

Depreciation (buildings and

care suites)

(6,193)-(144)(6,337)

Depreciation and amortisation

(chattels and software)

(2,949)-(580)(3,529)

Profit / (loss) before income tax

(449)50,346(16,441)33,456

Income tax benefit

583(877)3,7783,484

Profit / (loss) for the period

attributable to shareholders

13449,469(12,663)36,940

Other comprehensive income

Gain on revaluation of property,

plant and equipment for the

period, net of tax

22,488--22,488

Gain on revaluation of right of

use asset for the period, net of tax

119--119

Gain on cash flow hedges, net of tax

--3,1083,108

Total comprehensive income / (loss)

for the period attributable to

shareholders of the parent

22,74149,469(9,555)62,655

3535
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Six months ended 30 November 2020

(unaudited)

$NZ000’s

Care

Operations

Village

Operations

OtherTotal

Revenue

86,89916,569417103,885

Change in fair value of

investment property

-26,651-26,651

Change in fair value of right

of use investment property

-2,276-2,276

Other income

369747101,126

Total income

87,26846,243427133,938

Operating expenses

1

(76,287)(13,270)(10,740)(100,297)

Impairment of goodwill

(815)--(815)

Impairment of property, plant and

equipment and right of use buildings

(517)--(517)

Segment EBITDA

1

9,64932,973(10,313)32,309

Interest income

-31619

Finance costs

--(4,011)(4,011)

Depreciation (buildings and

care suites)

(4,925)-(124)(5,049)

Depreciation and amortisation

(chattels and software)

1

(2,481)-(413)(2,894)

Profit / (loss) before income tax

1

2,24332,976(14,845)20,374

Taxation benefit

1,298(6,667)9,8054,436

Profit / (loss) for the period

attributable to shareholders

1

3,54126,309(5,040)24,810

Other comprehensive income

Gain on revaluation of land and

buildings for the period, net of tax

31,231--31,231

Gain on revaluation of right of use

asset for the period, net of tax

27--27

Gain on cash flow hedges, net of tax

--918918

Total comprehensive income / (loss)

for the period attributable to

shareholders of the parent

1

34,79926,309(4,122)56,986

1

Comparatives have been restated for the impact of a change in accounting policy in regards

to the accounting for Software as a Service arrangements. Refer to note 1.2.

36
NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

ffCONTINUEDfi

For the six months ended 30 September 2021

36

OCEANIAINTERIM REPORT 2022

2.1 Operating Segments (continued)

Underlying net profit after tax (“Underlying Profit”)

Underlying Profit is a non-GAAP measure of financial performance and considered

in the determination of dividends. The calculation of Underlying Profit requires

a number of estimates to be approved by the Directors in their preparation.

Both the methodology and the estimates may differ among companies in the

retirement village sector. Underlying Profit does not represent cash flow generated

during the period.

The Group calculates Underlying Profit by making the following adjustments to

reported Net Profit after Tax:

Net profit after tax

RemoveChange in fair value of investment property, right of use investment

property assets and cash flow hedges and impairment / reversal of

impairment of property, plant and equipment and right of use

property, plant and equipment

Add backImpairment of goodwill

Add backRental expenditure in relation to right of use investment property

assets

Add back /

remove

Loss / gain on sale, decommissioning or purchase of assets and

business assets

Add backDepreciation (Care Suites)

Add backDirectors’ estimate of realised gains on the resale of units and care

suites sold under an ORA

Add backDirectors’ estimate of realised development margin on the first sale

of new ORA units or care suites following the development of an ORA

unit or care suite, conversion of an existing care bed to a care suite

or conversion of a rental unit to an ORA unit

Add backDeferred taxation component of taxation expense so that only the

current tax expense is reflected

=Underlying Profit

RemoveInterest income

Add backFinance costs (including lease interest under NZ IFRS 16 Leases

and excluding hedge ineffectiveness)

Add backDepreciation and amortisation (including right of use property, plant

and equipment)

=Underlying EBITDA

3737
CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Change to definition of Underlying Profit

The definition of Underlying Profit was amended for the first time in the 31 March

2021 consolidated annual financial statements to add back depreciation of care

suites. The comparative period figures have been restated to reflect this change.

The change allows for comparability of care suite assets, which are subject to an

ORA, with other village assets subject to an ORA which are treated as Investment

Property for GAAP purposes and are not depreciated. This change is consistent with

the management information used by the company and that which is reported to

the Board. The comparative period has been restated to add back depreciation on

care suites. This has increased Underlying Profit by $3.6m in the comparative period.

Resale gain – Underlying Profit

The Directors’ estimate of realised gains on resales of ORA units and care suites

(i.e. the difference between the incoming resident’s ORA licence payment and the

ORA licence payment previously received from the outgoing resident) is calculated

as the net cash flow received, and receivable at the point that the ORA contract

becomes unconditional and has either “cooled off” (the contractual period in which

the resident can cancel the contract) or where the resident is in occupation at

balance date.

Development margin – Underlying Profit

The Directors’ estimate of realised development margin is calculated as the

ORA licence payment received, and receivable, in relation to the first sale of

new ORA units and care suites, at the point that the ORA contract becomes

unconditional and has either “cooled off” or where the resident is in occupation

at balance date, less the development costs associated with developing the

ORA units and care suites. Where the development has been acquired in a

business combination the development costs are equal to the purchase price.

The Directors’ estimate of realised development margin for conversions is

calculated based on the difference between the ORA licence payment received,

and receivable, in relation to sales of newly converted ORA units and care suites,

at the point that the ORA contract becomes unconditional and has either “cooled

off” or where the resident is in occupation at balance date, and the associated

conversion costs.

38
2.1 Operating Segments (continued)

The table below describes the composition of development and conversion costs.

IncludedNew builds:

- the construction costs directly attributable to the relevant project, including

any required infrastructure (e.g. roads) and amenities related to the units

(e.g. landscaping) as well as any demolition and site preparation costs

associated with the project. The costs are apportioned between the ORA

units and care suites, in aggregate, using estimates provided by the project

quantity surveyor. The construction costs for the individual ORA units or care

suites sold are determined on a prorated basis using gross floor areas of the

ORA units and care suites;

- an apportionment of land value based on the gross floor area of the ORA

units and care suites developed. The value for Brownfield

1

development land

is the estimated fair value of land at the time a change of use occurred

2


(from operating as a care centre or retirement village to a development site),

as assessed by an external independent valuer. Greenfield

3

development

land is valued at historical cost; and

- capitalised interest costs to the date of project completion apportioned

using the gross floor area of ORA units and care suites developed.

Conversions:

- of care beds to care suites - the actual refurbishment costs incurred; and

- of rental units to ORA units - the actual refurbishment costs incurred and

the fair value of the rental unit prior to conversion.

Excluded- construction, land (apportioned on a gross floor area basis) and interest

costs associated with common areas and amenities or any operational

or administrative areas.

1

Brownfield land refers to land previously utilised by, or part of, an operational aged care centre

or retirement village.

2

The timing of a change of use is a Directors’ estimate. It is based on a range of factors including

evidence of steps taken to secure a resource consent and/or building consent for a particular

development or stage of a development and the decommissioning of existing operations (either

through the buy-back of existing village ORA units or decommissioning of an existing care centre).

Note the cost of buybacks is not included in the development cost as an independent fair value of

the land on an unencumbered basis is used as the value ascribed to the development land.

3

Greenfield land refers to land not previously utilised by, or as part of, an operational aged

care centre or retirement village. Greenfield land is typically bare (undeveloped) land at the

time of purchase.

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

38

OCEANIAINTERIM REPORT 2022

39
Six months ended 30 September 2021

(unaudited)

$NZ000’s

Care

Operations

Village

OperationsOtherTotal

Total comprehensive income for the

period attributable to shareholders

of the parent

22,74149,469(9,555)62,655

Adjusted for Proforma items

Add: Repayment of Wage Subsidy

1


1,768--1,768

Adjusted for Underlying Profit items

Less: Change in fair value of

investment property, right of use

assets and cash flow hedges and

impairment of property, plant

and equipment

(22,415)(32,284)(3,108)(57,807)

Add: Impairment of goodwill

338--338

Add: Rental expenditure in relation

to right of use asset

-1,928-1,928

Add: Depreciation (care suites)

4,807--4,807

Add: Loss / gain on sale,

decommissioning or purchase of

assets and business assets

-(8,588)-(8,588)

Add: Realised resale gain

-10,639-10,639

Add: Realised development margin

-15,252-15,252

Underlying net profit before tax

7,23936,416(12,663)30,992

Less: Deferred tax benefit

(583)877(3,778)(3,484)

Underlying net profit after tax

6,65637,293(16,441)27,508

Less: Interest income

-(3)(18)(21)

Add: Finance costs

(excluding hedge ineffectiveness)

--3,9213,921

Add: Depreciation (buildings)

1,386-1441,530

Add: Depreciation and amortisation

(chattels, leasehold improvements

and software)

2,949-5803,529

Underlying EBITDA

10,99137,290(11,814)36,467

1

On 21 April 2020 the Group claimed, and received payment of, a COVID-19 wage subsidy

totalling $1.8m. This amount has subsequently been repaid in full on 18 May 2021 and as a result

has been excluded from the table above. This proforma adjustment increases underlying EBITDA

and underlying NPAT in relation to the six month period to 30 September 2021 by $1.8m and

reduces the underlying EBITDA and underlying NPAT position in relation to the six month period

to 30 September 2020 by $1.8m. The statutory comparative period being the six months to

30 November 2020 is not impacted by this proforma adjustment.

39

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

40
2.1 Operating Segments (continued)

Six months ended 30 November 2020

(unaudited)

$NZ000’s

Care

Operations

Village

OperationsOtherTotal

Total comprehensive income for the

period attributable to shareholders

of the parent

34,79926,309(4,122)56,986

Adjusted for Underlying

Profit items

Less: Change in fair value of

investment property, right of use

assets and

cash flow hedges and impairment

of property, plant and equipment

(30,741)(28,927)(918)(60,586)

Add: Impairment of goodwill

815--815

Add: Rental expenditure in relation

to right of use asset

-3,330-3,330

Add: Loss / gain on sale,

decommissioning or purchase

of assets and business assets

--(84)(84)

Add: Depreciation (care suite)

1


3,576--3,576

Add: Realised gain on resale

-10,364-10,364

Add: Realised development margin

-16,981-16,981

Underlying net profit before tax

1

8,44928,057(5,124)31,382

Less: Deferred tax benefit

(1,298)6,667(9,805)(4,436)

Underlying net profit after tax

7,15134,724(14,929)26,946

Less: Interest income

-(3)(16)(19)

Add: Finance costs

--4,0114,011

Add: Depreciation (buildings)

1,349-1241,473

Add: Depreciation and amortisation

(chattels and software)

2,481-4132,894

Underlying EBITDA

10,98134,721(10,397)35,305

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

40

OCEANIAINTERIM REPORT 2022

1

The comparatives above have been restated to add back depreciation on care suites. This has

increased Underlying Profit by $3.6m in the comparative period.

41
3. Property Assets

The Group operates care centres and retirement villages. As outlined in section 2.1,

village sites are typically investment property and care sites are typically property,

plant and equipment.

What is Investment Property?

Land and buildings are classified as investment property when they are held to

generate revenue either through capital appreciation or through rental income.

As residents occupying our retirement villages live independently, the level of

services provided is seen as secondary to the provision of accommodation.

Accordingly, these buildings are classified as investment property as they are

held primarily to generate DMF income.

What is Property, Plant and Equipment?

Land, buildings and chattels are classified as property, plant and equipment

when they are used to generate revenue through the provision of goods and

services or for administration purposes.

As residents occupying our care centres, including care suites, require services

including nursing care, meals and laundry the buildings in which they live are

considered to be operated by the Group to generate this revenue and are

classified as property, plant and equipment.

What is a Care Suite?

Care suites are a premium offering for a resident requiring rest home or hospital

level care. The care suite is located within a care centre. Rather than pay a daily

premium accommodation charge for the provision of the premium room the

residents enter into an ORA with a net management fee.

Basis of valuation

CBRE Limited note in their 30 September 2021 report that, given the ongoing

uncertainty and unknown impact that COVID-19 might have on real estate markets

in the future, a degree of caution should be exercised when relying upon the

valuation. Values and incomes may change more rapidly and significantly than

during standard market conditions. To this end CBRE recommend that their

valuation is reviewed periodically over the coming months. In the comparative

period of 31 March 2021 CBRE Limited reported on the basis of “market uncertainty”

meaning that there remains uncertainty in the market because of the longer

economic impacts of COVID-19.

41

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

42
3. Property Assets (continued)

Classification of Serviced Apartments and Care Suites

Where services are provided to residents who occupy accommodation under an

ORA, it is the Group’s policy to assess their level of significance in the context of the

overall income derived from the serviced apartment or care suite in ascertaining

whether the serviced apartment or care suite is freehold land and buildings (referred

to as property, plant and equipment) or investment property.

The Group applies the following principles when ascertaining the appropriate

accounting treatment to be applied:

CLASSIFICATION

CONSIDERATION OF SIGNIFICANCE OF CASH FLOWS

SCENARIO

Additional services

are optional

Services are

compulsory but an

insignificant portion

of total revenue

from the unit

Services are

compulsory and a

significant portion

of the total revenue

from the unit

Full ARRC

1

funded

care is compulsory

for that unit/bed

Independent living

(villa or apartment)

Care suiteServiced apartmentTraditional care bed

Qualitatively the

business model is the

provision of retirement

accommodation

Quantitatively

insignificant

(a guideline of under

20% of total revenue

is adopted) and

qualitatively the

business model is the

provision of retirement

accommodation

Quantitatively

significant.

Qualitatively the

business model is the

provision of care

Qualitatively the

business model is

the provision of care.

Quantitative

assessment not

relevant as price of

accommodation does

not change overall

purpose of the

accommodation

Investment Property

Village Assets

Property, Plant and Equipment

Care Assets

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

42

OCEANIAINTERIM REPORT 2022

1

ARRC refers to age-related residential care.

43
3.1 Village Assets: Investment Property

$NZ000’s Notes

Unaudited

30 Sept 2021

Audited

31 Mar 2021

Investment property under development at fair value

Opening balance

143,720145,020

Capitalised expenditure (including land acquisitions)

56,89963,881

Capitalised interest and line fees

9953,028

Transfer to completed investment property

(7,721) (99,512)

Transfer to property, plant and equipment

(65)-

Change in fair value during the period –

developments as at balance date

6,537 7,826

Change in fair value during the period –

developments completed during the period

411 23,477

Closing balance

200,776 143,720

Completed investment property at fair value

Opening balance

956,083802,060

Acquisition

1


48,077-

Transfer from investment property under

development

3.2

7,721 99,512

Transfer to property, plant and equipment

- (1,329)

Capitalised expenditure

56,802 7,050

Capitalised interest and line fees

945 124

Disposals

- -

Change in fair value during the period –

existing villages

8,383 34,888

Change in fair value during the period –

recently completed developments

2

15,968 13,778

Closing balance

1,093,979 956,083

Total investment property

1,294,7551,099,803

43

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

1

Acquisition related to Waterford on Hobsonville Point. Refer to note 1.3 for details.

2

Recently completed developments refers to those developments which were being sold down

during the period.

44
3.1 Village Assets: Investment Property (continued)

Change in Fair Value Recognised in the Consolidated Statement

of Comprehensive Income

$NZ000’s

Unaudited

30 Sept 2021

Unaudited

30 Nov 2020

Increase in fair value of investment property

194,95265,420

Add: Transfers to property, plant and equipment and

to right of use assets during the period

651,329

Less: Capitalised expenditure including capitalised interest

(115,641)(40,818)

Less: Resident obligations on acquisition

(48,077)-

Add: Disposals

-720

Change in fair value recognised in

Consolidated Statement of Comprehensive Income

31,29926,651

Included in the above change in fair value is an amount of $6.6m (increase) in respect

to fair value moments since acquisition date of the Waterford site. The movement in

fair value has arisen predominantly on first sell down of vacant apartments.

A reconciliation between the valuation and the amount recognised on the

Consolidated Balance Sheet as investment property is as follows:

$NZ000’s

Unaudited

30 Sept 2021

Audited

31 Mar 2021

Investment Property under development

Valuation

200,776143,720

200,776143,720

Completed Investment Property

Valuation

528,134 474,215

Add: Refundable occupation licence payments678,896 573,766

Add: Residents' share of resale gains6,480 7,205

Less: Management fee receivable(102,245) (84,433)

Less: Resident obligations for units not included

in valuation

(17,286) (14,670)

1,093,979 956,083

Total investment property at fair value1,294,7551,099,803

Where an incoming resident has an unconditional ORA in respect of a retirement

village unit and the corresponding outgoing resident for that same accommodation

has not yet been refunded, the CBRE Limited valuation is adjusted for the incoming

resident balances only. In certain circumstances accommodation under an ORA is

valued as development land. In these situations the CBRE Limited valuation is not

adjusted for the refundable amounts and consequently no offsetting “gross up”

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

44

OCEANIAINTERIM REPORT 2022

45
is required. An adjustment of $17.3m (31 March 2021: $14.7m) is included in the above

reconciliation to reflect this.

The valuation of investment property is adjusted for cash flows relating to

refundable occupation licence payments, residents' share of resale gains and

management fee receivable recognised separately on the Consolidated Balance

Sheet and also reflected in the valuation model.

Why do we adjust for the liability to residents?

In the CBRE Limited valuation the fair value of investment property includes an

allowance for the amount that is payable by the Group to residents already

in occupation within the property. However, this liability to existing residents is

recognised in the Group’s Consolidated Balance Sheet (referred to as refundable

occupation right agreements – refer to note 3.3). Accordingly, the Group adds

this net liability to residents to the CBRE Limited valuation to “gross up” the fair

value of investment property and avoid double counting the liability to residents.

Valuation Process and Key Inputs

Investment Property under Development

CBRE Limited provided valuations of development land in respect of investment

property under development as at 30 September 2021.

The fair value of investment property is determined by the Directors having taken

into consideration the valuation conducted by CBRE Limited as an independent

registered valuer and the cost of work undertaken in relation to investment property

under development.

The Group has applied the following methodology in relation to the measurement

of investment property under development:

Practical completion not achieved

Where the development still requires substantial work such that practical

completion is not going to be achieved, and a reliable estimate of fair value cannot

be made, at or close to balance date, the fair value recognised is the fair value of

the development land per the Directors’ valuation plus the cost of any work in

progress. An amount of $86.4m as at 30 September 2021 (31 March 2021: $51.6m)

has been recognised in relation to these development sites.

Where an individual development is of both investment property and freehold

buildings in nature, the fair value of land and work in progress is apportioned

between investment property under development and freehold land and buildings

under development, by applying the estimated gross floor area for these respective

areas of the development based on information obtained from the project quantity

surveyors at the planning and design stages.

45

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

46
3.1 Village Assets: Investment Property (continued)

Practical completion achieved

Where a development is practically completed, or likely to be completed at,

or close to, balance date the investment property is measured at its completed

fair value per the Directors’ valuation with an adjustment made for any estimated

costs, in accordance with the project budget, to be incurred to complete the

development, and is then transferred to completed investment property.

Completed Investment Property

As required by NZ IAS 40 Investment Property, the valuation of investment property

is adjusted for cash flows relating to refundable occupation licence payments,

residents’ share of resale gains and management fees receivable recognised

separately on the Consolidated Balance Sheet and also reflected in the valuation

model.

The Group's interest in all completed investment property was valued on

30 September 2021 by CBRE Limited, at a total of $528.5m (31 March 2021:

$472.2m).

Investment Property Held for Sale

Investment property assets are classified as held for sale when their carrying

amount is to be recovered principally through a sale transaction and a sale is

considered highly probable. They are stated at their fair value.

Property Specific Assumptions

Seismic and Weather Tightness Assessments

The CBRE Limited valuation, and accordingly the fair value of investment property,

incorporates an allowance in relation to remediation to properties where seismic

strength testing has been carried out in prior years.

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

46

OCEANIAINTERIM REPORT 2022

47
3.2 Care Assets: Property, Plant and Equipment

$NZ000’s Notes

Freehold

Land and

Buildings

Under

Development

Freehold

Land

Freehold

Buildings

Chattels and

Leasehold

Improvements Total

Period ended

30 September 2021 (unaudited)

Opening net book amount

54,767 92,800 437,079 19,406 604,052

Additions17,8571,3433,2173,37725,794

Capitalised interest and

line fees

741-170-911

Disposals-----

Depreciation--(6,036)(2,458)(8,494)

Transfer from investment

property

3.165---65

Reclassification within

Property, Plant and

Equipment

320-(320)--

Revaluation surplus

Comprehensive income

Existing care centres

-(108)(205)-(313)

Care centres recently

developed / under

development

--49-49

Other comprehensive

income

1

Existing care centres2,03914,0552,424-18,518

Care centres recently

developed / under

development

--4,497-4,497

Closing net book amount

75,789108,090440,87520,325645,079

At 30 September 2021

(unaudited)

Cost

---54,92054,920

Valuation75,789108,090440,875- 624,754

Accumulated

depreciation

---(34,595)(34,595)

Net book amount75,789108,090440,87520,325645,079

47

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

1

The revaluation noted in the Statement of Comprehensive Income differs from the above due to

deferred tax, refer note 5.1.

48
3.2 Care Assets: Property, Plant and Equipment (continued)

$NZ000’s Notes

Freehold

Land and

Buildings

Under

Development

Freehold

Land

Freehold

Buildings

Chattels and

Leasehold

Improvements Total

Year ended 31 March 2021

(audited)

Opening net book amount

54,20677,496339,91618,372489,990

Additions 18,664 - 8,189 4,138 30,991

Capitalised interest and

line fees

837 - 271 - 1,108

Disposals - - - - -

Depreciation - - (8,121) (3,104)(11,225)

Transfer (to) / from

investment property

3.1 - - 1,329 - 1,329

Reclassification within

property, plant and

equipment

(32,998) (2,105) 35,103 - -

Revaluation surplus

Comprehensive income

Existing care centres

1,610 1,076 1,543 - 4,229

Care centres recently

developed / under

development

- - 75 - 75

Other comprehensive income

1

Existing care centres 2,007 16,333 31,757 - 50,097

Care centres recently

developed / under

development

10,441 - 27,017 - 37,458

Closing net book amount 54,767 92,800 437,079 19,406


604,052

At 31 March 2021 (audited)

Cost

- - - 51,543 51,543

Valuation 54,767 92,800 437,079 -


584,646

Accumulated depreciation - - - (32,137)


(32,137)

Net book amount 54,767 92,800


437,079 19,406


604,052

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

48

OCEANIAINTERIM REPORT 2022

49
Land and Buildings Under Development

A valuation in respect of development land was provided by CBRE Limited as at

30 September 2021.

Any costs incurred to 30 September 2021 on the developments are included in

arriving at the fair value as at 30 September 2021.

The Group has applied the following methodology in relation to the measurement

of land and buildings under development:

Practical completion not achieved

Where the development still requires substantial work such that practical

completion is not going to be achieved, and a reliable estimate of fair value

cannot be made, at or close to balance date, the fair value recognised is the fair

value of the development land per the Directors’ valuation plus the cost of any

work in progress. An amount of $34.0m as at 30 September 2021 (31 March 2021:

$16.2m) has been recognised in relation to these development sites.

Where an individual development is of both investment property and freehold

buildings in nature, the fair value of land and work in progress is apportioned

between investment property under development and freehold land and

buildings under development, by applying the estimated gross floor area for

these respective areas of the development based on information obtained from

the project quantity surveyors at the planning and design stages.

Practical completion achieved

Where a development is practically completed, or likely to be completed at, or

close to, balance date the land and buildings are measured at its completed fair

value per the Directors’ valuation with an adjustment made for any estimated

costs, in accordance with the project budget, to be incurred to complete the

development, and is then transferred to completed land and buildings.

Completed Land and Buildings

A valuation in respect of completed land and buildings was provided by CBRE

Limited as at 30 September 2021.

The valuation of the Group’s care centres was apportioned to land, buildings,

chattels and goodwill. The fair value of land and buildings as calculated by CBRE

Limited is based on the level of rent able to be generated from the maintainable

net cash flow of the site subject to average efficient management. The fair value

of the Group’s land and buildings as determined by the Directors is based on

these apportionments. However, chattels are carried at historic cost less

depreciation and the amount apportioned to goodwill by CBRE Limited is not

recorded in the consolidated interim financial statements. The CBRE Limited

valuation included $10.9m of goodwill (31 March 2021: $10.4m) in respect of

completed land and buildings.

The CBRE Limited valuation used in the determination of the fair value of freehold

buildings, incorporates an allowance in relation to remediation to properties

where seismic strength testing has been carried out in prior years.

49

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

50
3.2 Care Assets: Property, Plant and Equipment (continued)

Care Suites and Serviced Apartments

As discussed earlier in note 3, where services are provided to residents who occupy

accommodation under an ORA, it is the Group’s policy to look at the significance

of these services in the context of the overall revenue derived from the care suite

or serviced apartment in ascertaining whether the care suite or serviced apartment

is property, plant and equipment or investment property. Care suite residents

occupying accommodation under an ORA receive a significant level of services.

Hence, they are included in property, plant and equipment. Care suite land and

buildings are held at fair value.

Key Accounting Estimates and Judgements

All land and buildings have been determined to be Level 3 (31 March 2021: Level 3)

in the fair value hierarchy as the fair value is determined using inputs that are

unobservable.

3.3 Refundable Occupation Right Agreements

What’s an ORA?

An ORA is a contract which sets out the terms and conditions of occupation of

an independent living unit or care suite. A new resident is charged a refundable

occupation licence payment in consideration for the right to occupy one of the

Group's units, apartments or care suites. On termination of the ORA the

occupation licence payment is repaid to the exiting resident.

What’s DMF?

An amount equal to a capped percentage of the occupation licence payment is

charged by the Group as a management fee for the right of use and enjoy the

common areas of the village. The deferred management fee is payable by the

resident on termination of the ORA.

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

50

OCEANIAINTERIM REPORT 2022

51
$NZ000’s

Unaudited

30 Sept 2021

Audited

31 Mar 2021

Village

Refundable occupation licence payments

678,896573,766

Residents’ share of resale gains

6,4807,205

Less: Management fee receivable (per contract)

(139,346)(117,300)

546,030463,671

Leasehold Village

Refundable occupation licence payments

39,04537,130

Less: Management fee receivable (per contract)

(7,892)(6,647)

31,15330,483

Care Suites

Refundable occupation licence payments

170,530152,273

Accommodation rebate

137375

Less: Management fee receivable (per contract)(31,311)(28,369)

139,356124,279

Total refundable occupation right agreements716,539618,433

Reconciliation of Management Fees recognised under NZ IFRS and per ORA

$NZ000s

Unaudited

30 Sept 2021

Audited

31 Mar 2021

Village

Management fee receivable (per contract)

(139,346)(117,300)

Deferred management fee

37,10132,867

Management fee receivable (per NZ IFRS)(102,245)(84,433)

Leasehold Villages

Management fee receivable (per contract)

(7,892)(6,647)

Deferred management fee2,9102,590

Management fee receivable (per NZ IFRS)(4,982)(4,057)

Care Suites

Management fee receivable (per contract)

(31,311)(28,369)

Deferred management fee6,0226,042

Management fee receivable (per NZ IFRS)(25,289)(22,327)

51

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

52
3.4 Leases

What’s a right of use asset?

Right of use assets are assets held under a lease arrangement. It represents

the value of the lessee’s right of use an asset over the life of the lease. There is

a corresponding lease liability on the Consolidated Balance Sheet which

represents the present value of the future lease payments.

Right of use Assets

$NZ000’s

Period ended 30 September 2021

Investment

Property

Land and

BuildingsChattelsTotal

Opening net book value

33,4464,1694,09941,714

Additions

5158300463

Disposals

-(1,034)-(1,034)

Depreciation

-(301)(920)(1,221)

Revaluation for the period –

Comprehensive Income

98671-1,057

Revaluation for the period

1


Other Comprehensive Income

-165-165

Net book value as at

30 September 2021 (unaudited)

34,4373,2283,47941,144

$NZ000’s

Year ended 31 March 2021

Investment

Property

Land and

BuildingsChattelsTotal

Opening net book value

31,1404,8374,84540,822

Additions

733872912

Disposals

-(266)(9)(275)

Depreciation

-(494)(1,609)(2,103)

Revaluation for the period –

Comprehensive Income

2,299(37)-2,262

Revaluation for the period

1


Other Comprehensive Income

-96-96

Net book value as at

31 March 2021 (audited)

33,4464,1694,09941,714

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

52

OCEANIAINTERIM REPORT 2022

1

The revaluation noted in the Statement of Comprehensive Income differs from the above due to

deferred tax, refer note 5.1.

53
$NZ000’s

30 September 2021

Investment

Property

Land and

BuildingsChattelsTotal

Cost

--8,9098,909

Valuation

34,4373,228-37,665

Accumulated depreciation

--(5,430)(5,430)

Net book value as at

30 September 2021 (unaudited)

34,4373,2283,47941,144

A reconciliation between the valuation and the amount recognised on the

Consolidated Balance Sheet as right of use investment property is as follows:

$NZ000’s

Unaudited

30 Sept 2021

Audited

31 Mar 2021

Right of use Investment Property

Valuation

374373

Add: Refundable occupation licence payments

39,04537,130

Less: Management fee receivable

(4,982)(4,057)

34,43733,446

The valuation of right of use investment property is adjusted for cash flows relating

to refundable occupation licence payments and management fee receivable

recognised separately on the Consolidated Balance Sheet and also reflected

in the valuation model.

Lease Liabilities

$NZ000’s

30 September 2021

Investment

Property

Land and

BuildingsChattelsTotal

Opening net book value

-7,0214,49211,513

Additions

-158300458

Disposals

(1,750)-(1,750)

Interest

-133168301

Lease payments made

-(445)(1,301)(1,746)

Lease liabilities as at

30 September 2021 (unaudited)

-5,1173,6598,776

$NZ000’s

31 March 2021

Investment

Property

Land and

BuildingsChattelsTotal

Opening net book value

-7,8655,13613,001

Additions and disposals

-(349)863514

Interest

-352345697

Lease payments made

-(847)(1,852)(2,699)

Lease liabilities as at

31 March 2021 (audited)

-7,0214,49211,513

53

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

54
3.4 Leases (continued)

Lease of Investment Property

The Group leases one site, Everil Orr, which meets the definition of investment

property. The site comprises both apartments and common facilities provided for

use by residents under the terms of an ORA. Payments to the lessor under this lease

are made as ORAs are sold. Subsequent cash flows upon the sale and resale of the

units are shared between the lessor and the Group.

Due to the variability of these payments both the right of use asset and the

corresponding lease liability were initially recognised at nil value. Rental payments

are recognised as a rental expense through the Consolidated Statement of

Comprehensive Income. The right of use asset is held at fair value in accordance

with NZ IAS 40 Investment Property. The fair value is determined by the Directors

having taken into consideration the valuation conducted by CBRE Limited.

The carrying value of the right of use asset as at 30 September 2021 in respect

of this leased site is $34.4m (31 March 2021: $33.4m).

On 15 February 2021 the Group entered into a Sale and Purchase Agreement to

purchase one leased site for a purchase price of $5.0m. Date of settlement was

18 June 2021. NZ IFRS 16 Leases states that any difference in purchase price and

the carrying amount of the lease liability immediately before the purchase shall be

recorded as an adjustment to the carrying amount of the asset. The carrying value

at the date of acquisition was $1.0m with a corresponding liability of $1.8m.

Lease of Property, Plant and Equipment

The Group leases two care centres (31 March 2021: three care centres) which are

valued as right of use assets as well as on one support office building and various

equipment and motor vehicles.

A valuation in respect of right of use property assets was provided by CBRE Limited

as at 30 September 2021.

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

54

OCEANIAINTERIM REPORT 2022

55
4. Shareholder Equity and Funding

4.1 Shareholder Equity and Reserves

Unaudited

30 Sept 2021

Shares

Audited

31 Mar 2021

Shares

Unaudited

30 Sept 2021

$NZ000’s

Audited

31 Mar 2021

$NZ000’s

Share capital

Authorised, issued and

fully paid up capital

705,705,859689,276,946700,717675,625

Total contributed equity

705,705,859689,276,946700,717675,625

Movements

Opening balance of

ordinary shares issued

689,276,946618,056,183675,625588,389

Shares issued for employee

share scheme

-1,193,045--

Shares issued for dividend

reinvestment plan

3,963,6598,489,2565,5679,175

Share issue (placement)15,629,81061,538,46220,00080,000

Capitalised costs in relation

to share placement

--(475)(1,939)

Treasury shares reacquired(3,164,556)---

Share issue (rights issue)----

Capitalised costs in relation

to rights issue

----

Closing balance of ordinary

shares issued

705,705,859689,276,946700,717675,625

All ordinary shares are authorised and rank equally with one vote attached to

each fully paid ordinary share. The shares have no par value. The Company

incurred no transaction costs issuing shares during the period (31 March 2021: nil).

Share Issue (Placement)

On 29 March 2021 a total of 61,538,462 shares with a value of $1.30 per share

were issued in relation to an Institutional Placement. These shares rank equally

with existing shares. The Placement was fully underwritten. Fees incurred of

$1.9m have been offset against funds raised.

Share Issue (Rights Issue)

On 16 April 2021, a total of 15,619,810 ordinary shares with a value of $20.0m

($1.2796 per share) were issued in relation to the Retail Offer.

55

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

56
4.1 Shareholder Equity and Reserves (continued)

Dividend Reinvestment Plan (“DRP”)

– 3,963,659 shares with a value of $1.4040 per share were issued in the six months

to 30 September 2021 in relation to the 31 March 2021 dividend reinvestment plan.

– 1,399,054 shares with a value of $1.5331 per share were issued in the four months

to 31 March 2021 in relation to the 30 November 2020 dividend reinvestment plan.

– 2,613,632 shares with a value of $0.9910 per share were issued in the six months

to 30 November 2020 in relation to the 31 May 2020 dividend reinvestment plan.

Further, 4,476,570 shares with a value of $0.9910 were issued in the six months

to 30 November 2020 pursuant to an underwriting agreement with Macquarie

Securities (NZ) Limited.

Recognition and Measurement

– On 6 September 2021, 1,078,125 share rights were issued for nil consideration and

a nil exercise price in relation to the LTI Scheme for the provision of performance

based remuneration.

– On 1 September 2021 the Group acquired 3,164,556 shares held by OCA Employees

Trustee Limited, a subsidiary, in relation to a previously cancelled long term

incentive plan scheme. The shares had been classified as Treasury Shares as the

Group had a beneficial interest in the 3,164,556 shares.

– On 20 November 2020, 1,948,061 share rights were issued for nil consideration

and a nil exercise price in relation to the LTI Scheme for the provision of

performance-based remuneration. Since that point a total of 1,252,325 share

rights that were granted at that time have lapsed as a consequence of executives

leaving employment with the Company.

Group Structure

There are no major shareholders.

Dividends

On 29 November 2021, an interim dividend of 2.1 cents per share (not imputed)

was declared and will be paid on 20 December 2021. The record date for

entitlement is 6 December 2021.

Unaudited

30 Sept 2021

cents per share

Unaudited

30 Sept 2021

$NZ000’s

Audited

31 Mar 2021

cents per share

Audited

31 Mar 2021

$NZ000’s

Final dividend for the prior year

2.114,4751.27,417

Interim dividend for the period --1.38,142

Total dividends declared during

the period

1

-14,475-15,559

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

56

OCEANIAINTERIM REPORT 2022

1

Total dividends declared during the period differs to dividends paid per the Consolidated Statement

of Changes in Equity as a result of dividends payable on shares held within the Group.

57
Dividend Reinvestment Plan

On 25 July 2019, the Board approved the implementation of a dividend reinvestment

plan for New Zealand and Australian shareholders. This plan has been effective for

all subsequent dividends. This plan shall also be effective for the dividend payable

on 20 December 2021 at a discount of 2.5% to the volume weighted average price

of shares sold on the NZX Main Board over a period of five trading days starting on

3 December 2021. The dividend reinvestment plan shall apply to those shareholders

who have provided a participation election by 5:00pm on the dividend election

date, being 7 December 2021.

Asset Revaluation Reserve

The asset revaluation reserve is used to record the revaluation of freehold land and

buildings and land and buildings under development.

Cash Flow Hedge Reserve

The cash flow hedge reserve is used to record gains or losses on instruments used

as cash flow hedges. The amounts are recognised in the Consolidated Statement

of Comprehensive Income when the hedged transaction affects profit or loss.

Refer to note 5.6 of the 31 March 2021 consolidated annual financial statements.

Long Term Incentive Plan

On 15 September 2020 the Board approved a new Long Term Incentive Scheme

for its senior executives (“LTI Scheme”). The LTI Scheme has been established to:

– provide an incentive to key executives to commit to Oceania for the long term; and

– align these executives’ interests with the interests of Oceania’s shareholders.

Participants in the Scheme will be granted Share Rights from time to time which

will, on vesting, convert into an entitlement to receive ordinary shares. Vesting will

depend on achievement of certain performance hurdles relating to Oceania’s total

shareholder return relative to the NZX50, and Oceania’s performance against

EBITDA targets.

Share Rights become exercisable if the holder remains employed on the vesting

date and performance hurdles are met over the period from the commencement

date to the measurement date, and in certain other exceptional circumstances.

On becoming exercisable, each Share Right will entitle the holder to receive one fully

paid ordinary share in Oceania Healthcare Limited, less an adjustment for tax paid

on the holder’s behalf for the benefit received under the Scheme. The Share Rights

have a nil exercise price.

57

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

58
4.1 Shareholder Equity and Reserves (continued)

Performance Hurdles

The Share Rights in each grant are divided between two performance hurdles;

– Share Rights will qualify for vesting on a straight-line basis, from 0%, where the total

shareholder return (“TSR”) from the commencement date to the measurement date

is equal to the 35th percentile of the NZX50 Group, to 100% where the TSR is equal

to or greater than the 75th percentile of the NZX50 Group; and

– For the second performance hurdle, Share Rights will qualify for vesting if the

Group’s annual growth in underlying earnings (before interest, tax, depreciation

and amortisation) per share (UEPS) from the commencement date to the

measurement date is equal to or greater than the target for growth in UEPS

for that period.

Lapse

– Share Rights will lapse where the performance hurdles are not met on a relevant

measurement date or, in general, where the participant ceases to be employed by

the Group before the vesting date (except in certain circumstances).

Employee Share Scheme

On 22 September 2020 1,193,045 shares were issued as part of an employee

share scheme (“ESS”). All permanent employees as at that date were invited to

participate. Full time employee participants were allocated an equivalent of $800

of shares and part time employee participants were allocated an equivalent of

$400 of shares. The shares are held in trust and will be transferred to the employee

if the employee remains employed by Oceania (or any of its subsidiaries) for the

following three years.

4.2 Earnings per Share

Basic

Basic earnings per share is calculated by dividing the profit after tax of the Group

by the weighted average number of ordinary shares outstanding during the period.


Unaudited

30 Sept 2021

Unaudited

30 Nov 2020

Profit after tax ($’000)

36,94024,810

1

Weighted average number of ordinary shares outstanding

('000s)

702,542619,514

Basic earnings per share (cents per share)

5.34.0

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

58

OCEANIAINTERIM REPORT 2022

1

Comparatives have been restated for the impact of a change in accounting policy in regards

to the accounting for Software as a Service arrangements. Refer to note 1.2.

59
Diluted

Diluted Earnings per share is calculated by adjusting the weighted average

number of ordinary shares outstanding to assume conversion of all dilutive

potential ordinary shares. As at 30 September 2021 there were no shares with

a dilutive effect (30 November 2020: nil).


Unaudited

30 Sept 2021

Audited

30 Nov 2020

Profit / (loss) after tax ($’000)

36,94024,810

Diluted weighted average number of ordinary shares

outstanding ('000s)

702,542619,514

Diluted earnings per share (cents per share)

5.34.0

4.3 Borrowings

$NZ000’s

Unaudited

30 Sept 2021

Audited

31 Mar 2021

Secured

Bank loans

125,785204,930

Deferred payment on acquisition of previously leased site

3,500-

Capitalised loan costs

(371)(473)

Retail bond – OCA010

125,000125,000

Retail bond – OCA020

100,000-

Capitalised bond costs

(3,185)(2,165)

Total borrowings

350,729327,292

Current

3,250-

Non current

351,035329,930

Total borrowings excluding capitalised loan costs

354,285329,930

Recognition and Measurement

Bank Loans

Interest is charged using the BKBM Bill rate plus a margin and line fee. Interest rates

applicable in the six month period to 30 September 2021 ranged from 1.64% to 1.96%

(period to 31 March 2021: 2.40% to 2.58%).

Deferred Payment on Acquisition of Previously Leased Site

Relates to the purchase of a previously leased site. The deferred payment is secured

by a first charge mortgage over the property.

No interest is charged unless the payment is in default. Refer to note 3.4.

59

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

60
4.3 Borrowings (continued)

Retail Bond

On 13 September 2021 the Group issued 100.0m additional bonds totalling $100.0m

with a maturity date of 13 September 2028. The bonds are listed on the NZX Debt

Market (NZDX) with the ID OCA020. The bond has a fixed interest rate of 3.3%.

In the comparative period the Group issued 125.0m retail bonds totalling $125.0m

on 19 October 2020 with a maturity date of 19 October 2027 at a fixed interest rate

of 2.3%. The bonds have the NZDX ID of OC010.

The bonds are quoted on the NZX Debt Market and their fair value at balance

date is based on their listed market price as at balance date. Interest on OCA010

is payable quarterly in January, April, July and October in equal instalments.

Interest on OCA020 is payable quarterly in March, June, September and December

in equal instalments. The bonds were trading as follows:

Yield

Unaudited

30 Sept 2021

Audited

31 Mar 2021

OCA010

2.8%2.7%

OCA020

2.9%n/a

Debt Financing

Total debt facility limits are $350.0m. The General Corporate Facility limit is $85.0m

and the Development Facility limit is $265.0m.

The maturity of the Facilities is 31 July 2023.

Financing Arrangements

At 30 September 2021, the Group held committed bank facilities with drawings

as follows:

Unaudited

30 Sept 2021

Audited

31 Mar 2021

$NZ000’sCommittedDrawnCommittedDrawn

General Corporate Facility

85,0006,00085,000-

Development Facility

265,000119,785265,000204,930

Total

350,000125,785350,000204,930

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

60

OCEANIAINTERIM REPORT 2022

61
The Group’s revolving Development Facility is utilised to cover costs associated with

current development projects. The revolving General Corporate Facility is used for

general corporate purposes as well as for development land and initial costs for

projects not currently funded by the Development Facility.

Interest on the General Corporate Facility is typically payable quarterly. Interest on

the Development Facility is capitalised and repaid together with principal using the

ORA licence proceeds received upon settlement of initial sales of newly developed

units and care suites. Line fees are payable quarterly on the committed General

Corporate Facility and the Committed Development Facility.

The financial covenants in the Group’s senior debt facilities, with which the Group

must comply include:

a) Interest Cover Ratio – the ratio of Adjusted EBITDA to Net Interest Charges is not

less than 2.0x;

b) Loan to Value Ratio – the ratio of total bank indebtedness shall not exceed 50%

of the total property value of all Group’s properties (including the “as-complete”

valuations for projects funded under the Development Facility); and

c) Guarantor Group Coverage – at all times the adjusted EBITDA of the

Guaranteeing Group must be at least 90% of the Adjusted EBITDA of the total

tangible assets of the Group; and

d) Development – At all times the outstanding principal amount under the

Development Facility shall not exceed the Development Value. Development

Value (per the most recent valuation excluding any settled stock) is the

aggregate value of all Residential Facilities in all Developments that are

being funded by the Development Facility less their cost to complete.

The covenants are tested half yearly. All covenants have been complied with

during the year. The Group has agreed with its banks that the calculation of

Adjusted EBITDA and Net Interest, for the purposes of the financial covenants,

shall continue to be based on the accounting treatment in use before the

introduction of NZ IFRS 16 Leases.

Assets Pledged as Security

The bank loans and bonds of the Group are secured by mortgages over the

Group’s care centre freehold land and buildings and rank second behind the

Statutory Supervisors where the land and buildings are classified as investment

property and investment property under development.

As at 30 September 2021 the balance of the bank loans and bonds over which

the properties are held as security is $350.8m (31 March 2021: $329.9m).

61

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

62
5. Other Disclosures

5.1 Income Tax

What is Current Tax?

Current tax is an estimate of the tax that is payable to Inland Revenue for the

current financial period.

What is Deferred Tax?

Deferred tax is an estimate of income tax that will be payable or recoverable in

respect of temporary differences relating to the accounting and tax values of the

Group’s assets and liabilities. Deferred tax also includes the value of tax losses

that we consider we will use in the future to meet any income tax obligation.

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

62

OCEANIAINTERIM REPORT 2022

63
$NZ000’s

Unaudited

30 Sept 2021

Unaudited

30 Nov 2020

Income tax benefit

Current tax

- -

Deferred tax(3,484)(4,436)

(3,484)(4, 436)

Taxation expense is calculated as follows:

Profit / (loss) before income tax

33,45620,491

Tax at the New Zealand tax rate of 28% 9,3685,737

Adjusted by the tax effect of:

Non-deductible impairment of goodwill

95228

Non-deductible expenditure245285

Capitalised interest deductible for tax(798)(745)

Taxable deferred management fees(5,738)(1,934)

Non-assessable revaluation of investment property(9,039)(8,100)

Taxable depreciation(2,810)(3,510)

Accounting depreciation2,4741,856

Right of use asset(28)9

Non-deductible impairment / (reversal of non-

deductible impairment) of fixed asset

54145

Adjustment for timing difference of provisions166832

Other-(39)

Losses generated

6,0115,236

Current tax expense

--

Impact of movements in investment property

(2,256)480

Impact of movements in property, plant and

equipment

(719)(1,671)

Impact of movements in right of use assets

121(92)

Other adjustments

(309)(912)

Deferred management fee

3,2961,934

Other deferred tax assets not recognised

(336)-

Prior period adjustments: other

--

Losses utilised or derecognised

(3,281)(4,175)

Deferred tax benefit

(3,484)(4,436)

Income tax benefit

(3,484)(4,436)

63

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

64
5.1 Income Tax (continued)

Movement in the Deferred Tax Balance:

$NZ000’s

Balance

1 Apr

2021

Audited

Recognised in

Consolidated

Statement of

Comprehensive

Income

Recognised

in Other

Comprehensive

Income

Balance

30 Sept

2021

Unaudited

Investment property

3,189 2,878-6,067

Property, plant and equipment

(13,520)719(527)(13,328)

Right of use assets

902 (121)(46)735

Provisions and other assets /

liabilities

7,979 309(1,091)7,197

DMF revenue in advance

1,786 (5,738)-(3,952)

Tax losses

- 3,281-3,281

Deferred tax assets not recognised

(336)336--

Deferred tax (liabilities) / assets

- 1,664

1

(1,664)-

$NZ000’s

Balance

1 Jun

2020

Audited

Recognised in

Consolidated

Statement of

Comprehensive

Income

Recognised

in Other

Comprehensive

Income

Balance

31 Mar

2021

Audited

Investment property

(960) 4,149 - 3,189

Property, plant and equipment

(14,651) 10,103 (8,972) (13,520)

Right of use assets

929 8 (35) 902

Provisions and other assets /

liabilities

8,645 723 (1,389) 7,979

DMF revenue in advance

5,538 (3,752) - 1,786

Tax losses

499 (499) - -

Deferred tax assets not recognised

- (336) - (336)

Deferred tax (liabilities) / assets

- 10,396 (10,396) -

Recognition and Measurement

No income tax was paid or payable during the year (31 March 2021: nil).

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

64

OCEANIAINTERIM REPORT 2022

1

Included in this movement is a $1.8m liability in regards to deferred tax on the Waterford

business combination. The impact of this offsets the Gain on the Purchase of Business Assets

within the Statement of Comprehensive Income.

65
Key accounting judgements

Deferred Tax on Investment Property

Deferred tax on investment property is assessed on the basis that the asset value

will be realised through use (“Held for Use”). An initial recognition exemption has

been applied to newly developed village sites in accordance with NZ IAS 12.

The Group’s ORAs comprise two distinct cash flows (being an ORA deposit upon

entering the unit and the refund of this deposit upon exit). In determining the tax

base of investment property, the Group considered whether taxable cash flows are

received at the end of the ORA period (i.e. upon refund of the ORA deposit by way

of set off on exit by a resident) or at the beginning of the ORA period (i.e. at time of

the receipt of the ORA deposit). The Group has carefully evaluated all the available

information and considers it appropriate to recognise and measure the tax base

and associated deferred tax based on the taxable cash flows being receivable at the

end of the ORA period as this best represents the Group’s contractual entitlement.

In calculating deferred tax under the Held for Use methodology, the Group has

made significant judgements to determine taxable temporary differences. The

carrying value of the Group’s investment property is determined on a discounted

cash flow basis and includes cash flows that are both taxable and non-taxable in

the future. The Group has recognised deferred tax on the cash flows with a future

tax consequence being DMF and deductible amounts as provided by CBRE Limited,

to the extent that it doesn’t relate to land. The Group uses the CBRE Limited valuation

of land and improvements to estimate the apportionment of cash flows arising from

the depreciable (i.e. buildings) and non-depreciable components (i.e. land).

Recognition of Deferred Tax on Deferred Management Fee

The interpretation of New Zealand tax laws in relation to DMF involves significant

judgements and uncertainty.

During October 2018, the Group obtained a binding ruling from Inland Revenue,

applicable for ORAs entered into after 1 June 2018 with certain revisions to the

terms and conditions relating to the DMF. Pursuant to this ruling DMF revenue is

recognised as derived on the exit of a unit or care suite by a resident.

Recognition of Deferred Tax on Tax Losses

The Company and its subsidiaries exited the former OHHL tax consolidated group

from 31 May 2015. All tax losses incurred by the Company and its subsidiaries until

31 May 2015 are tax losses of the OHHL consolidated tax group (of which the Group

is no longer a member).

After taking into consideration losses generated in the period to 30 September 2021,

the Group now has an estimated $108.5m (31 March 2021: $86.9m) of available tax

losses as at 30 September 2021.

The Group may recognise deferred tax assets to the extent that it is probable that

the Group will generate future economic profits to offset the deferred tax assets or

to the extent that they offset deferred tax liabilities. All available losses generated

are held off balance sheet.

65

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

66
5.2 Contingencies and Commitments

At 30 September 2021, the Group had no contingent liabilities or assets (31 March

2021: nil).

At 30 September 2021, the Group has a number of commitments to develop and

construct certain sites totalling $108.5m (31 March 2021: $131.4m) of which $108.5m

(31 March 2021: $131.4m) relates to development sites.

As at 30 September 2021, a commitment of $9.3m (31 March 2021: $9.3m) exists in

relation to Stage One and $3.0m (31 March 2021: $5.8m) in relation to Stage Two

in the form of future lease payments in respect of the development of Everil Orr, a

leasehold site. Lease payment obligations arise as ORAs are sold. Refer to note 3.4

for further details.

There are no significant unrecognised contractual obligations entered into for future

repairs and maintenance at balance date.

5.3 Events After Balance Date

Employee Share Scheme

Post balance date, but before the signing of these financial statements, all employees

of the Group were invited to participate in the 2021 employee share scheme. Shares in

relation to those employees who choose to participate will be issued post the signing

date of these interim financial statements.

Dividend

On 29 November 2021 an interim dividend of 2.1 cents per share (not imputed) was

declared and will be paid on 20 December 2021. The record date for entitlement is

6 December 2021. Refer to note 4.1.

Land Purchase

During November 2021 a sale and purchase agreement was entered into to purchase

a piece of bare land neighbouring the Franklin site at market value. The agreement is

conditional on the Group's due diligence process.

There have been no other significant events after balance date.

NOTES TO THE CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

(CONTINUED)

For the six months ended 30 September 2021

66

OCEANIAINTERIM REPORT 2022

PwC Tower, 15 Customs Street West, Private Bag 92162, Auckland 1142, New Zealand
T: +64 9 355 8000, www.pwc.co.nz

Independent auditor’s report

To the shareholders of Oceania Healthcare Limited

We have audited the consolidated financial statements which comprise:

•the consolidated balance sheet as at 31 May 2019;

•the consolidated statement of comprehensive income for the year then ended;

•the consolidated statement of changes in equity for the year then ended;

•the consolidated cash flow statement for the year then ended; and

•the notes to the consolidated financial statements, which include significant accounting policies.


Our opinion

In our opinion, the accompanying consolidated financial statements of Oceania Healthcare Limited

(the Company), including its subsidiaries (the Group), present fairly, in all material respects, the

financial position of the Group as at 31 May 2019, its financial performance and its cash flows for the

year then ended in accordance with New Zealand Equivalents to International Financial Reporting

Standards (NZ IFRS) and International Financial Reporting Standards (IFRS).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (New Zealand) (ISAs

(NZ)) and International Standards on Auditing (ISAs). Our responsibilities under those standards are

further described in the Auditor’s responsibilities for the audit of the consolidated financial

statements section of our report.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for

our opinion.

We are independent of the Group in accordance with Professional and Ethical Standard 1 (Revised)

Code of Ethics for Assurance Practitioners (PES 1) issued by the New Zealand Auditing and Assurance

Standards Board and the International Ethics Standards Board for Accountants’ Code of Ethics for

Professional Accountants (IESBA Code), and we have fulfilled our other ethical responsibilities in

accordance with these requirements.

Our firm carries out other services for the Group in the areas of trustee reporting, tax advisory and

market research. The provision of these other services has not impaired our independence as auditor

of the Group.

67

CONSOLIDATED INTERIM FINANCIAL STATEMENTS

INDEPENDENT AUDITOR'S REVIEW REPORT

To the shareholders of Oceania Healthcare Limited




PricewaterhouseCoopers, 15 Customs Street West, Private Bag 92162, Auckland 1142, New Zealand

T: +64 9 355 8000, F: +64 9 355 8001, pwc.co.nz



Independent auditor’s review report

To the shareholders of Oceania Healthcare Limited


Report on the consolidated interim financial statements

Our conclusion

We have reviewed the consolidated interim financial statements of Oceania Healthcare Limited (the

“Company”) and its subsidiaries (the “Group"), which comprise the consolidated balance sheet as at

30 September 2021, and the consolidated statement of comprehensive income, the consolidated

statement of changes in equity and the consolidated cas h flow statement for the six months ended on

that date, and significant accounting policies and other explanatory information.

Based on our review, nothing has come to our attention that causes us to believe that the

accompanying consolidated interim financial statements of the Group do not present fairly, in all

material respects, the financial position of the Group as at 30 September 2021, and its financial

performance and cash flows for the period then ended, in accordance with International Accounting

Standard 34 Interim Financial Reporting (IAS 34) and New Zealand Equivalent to International

Accounting Standard 34 Interim Financial Reporting (NZ IAS 34).

Basis for conclusion

We conducted our review in accordance with the New Zealand Standard on Review Engagements

2410 (Revised) Review of Financial Statements Performed by the Independent Auditor of the Entity

(NZ SRE 2410 (Revised)). Our responsibility is further described in the Auditor’s responsibility for the

review of the consolidated financial statements section of our report.

We are independent of the Group in accordance with the relevant ethical requirements in New

Zealand relating to the audit of the annual financial statements, and we have fulfilled our other ethical

responsibilities in accordance with these ethical requirements. In addition to our role as auditor, our

firm carries out other services for the Group in the areas of trustee reporting, Environmental, Social

and Governance (ESG) reporting and agreed upon procedures in respect of proxy voting at the Annual

Shareholders Meeting. The provision of these other services has not impaired our independence.

Directors’ responsibility for the consolidated interim financial statements

The Directors of the Company are responsible on behalf of the Company for the preparation and fair

presentation of these consolidated interim financial statements in accordance with IAS 34 and NZ IAS

34 and for such internal control as the Directors determine is necessary to enable the preparation and

fair presentation of consolidated interim financial statements that are free from material misstatement,

whether due to fraud or error.

Auditor’s responsibility for the review of the consolidated interim financial statements

Our responsibility is to express a conclusion on the consolidated interim financial statements based on

our review. NZ SRE 2410 (Revised) requires us to conclude whether anything has come to our

attention that causes us to believe that the consolidated interim financial statements, taken as a whole,

are not prepared in all material respects, in accordance with IAS 34 and NZ IAS 34. A review of

consolidated interim financial statements in accordance with NZ SRE 2410 (Revised) is a limited

assurance engagement. We perform procedures, primarily consisting of making enquiries, primarily of

persons responsible for financial and accounting matters, and applying analytical and other review

procedures.


INDEPENDENT AUDITOR'S REVIEW REPORT (CONTINUED)
To the shareholders of Oceania Healthcare Limited

6868

OCEANIAINTERIM REPORT 2022



PwC

2


The procedures performed in a review are substantially less than those performed in an audit

conducted in accordance with International Standards on Auditing and International Standards on

Auditing (New Zealand) and consequently does not enable us to obtain assurance that we might

identify in an audit. Accordingly, we do not express an audit opinion on these consolidated interim

financial statements


Who we report to

This report is made solely to the Company’s shareholders, as a body. Our review work has been

undertaken so that we might state to the Company’s shareholders those matters which we are

required to state to them in our review report and for no other purpose. To the fullest extent permitted

by law, we do not accept or assume responsibility to anyone other than the shareholders, as a body,

for our review procedures, for this report, or for the conclusion we have formed.


The engagement partner on the review resulting in this independent auditor’s review report is Leopino

Foliaki.


For and on behalf of:








Chartered Accountants Auckland

29 November 2021


oceaniahealthcare.co.nz

---

Believe
in better.

RESULTS PRESENTATION FOR THE FINANCIAL HALF YEAR ENDED 30 SEPTEMBER 2021

2
Introduction

3

Our new directors

4

COVID-19 update

5

1HY2022 trading highlights

7

Update on developments

10

Financial results

17

Appendices

29

Agenda

3
•New Zealand was been subject to Alert Level 3 restrictions or higher for 21 days in

1HY2022 (43 days in pcp2021).

•In addition to national lockdowns the Auckland region has been subject to Alert

Level 3 restrictions or higher for a further 23 days in 1HY2022 (i.e. 44 days in total;

43 days in pcp2021).

Introduction

This is the first half-year results presentation since the change of balance date to 31 March

1

.

Oceania recorded a number of highlights in the period despite the disruptions of COVID-19 lockdowns.

1.Oceania changed its balance date to 31 March (previously 31 May) for the financial year ended 31 March 2021

2.The COVID wage subsidy of $1.8m was received in April 2020 and repaid in May 2021. Both 1HY2022 and pcp2021 have been proforma adjusted to exclude the receipt and subsequent repayment of the wage

subsidyrespectively. The unadjusted results for EBITDA and NPAT are $34.7m and $25.8m respectively for 1HY2022 ($32.3m and $24.3m respectively for pcp2021)

The focus of this presentation will be comparing the pro-forma 6 months of

trading to 30 September 2021 (“1HY2022”) with pro-forma comparative 6 month

period to 30 September 2020 (“pcp2021” or prior corresponding period, “pcp”).

Comparison with prior period

COVID-19 impact on periods

6 months to 30 SeptemberGrowth

NZDm

2021

1HY2022

2020

pcp2021

Δ

%

Proforma Group Underlying EBITDA ($m)

2

36.530.56.019.7%

Proforma Underlying NPAT ($m)

27.522.55.022.2%

Sales volume

2302082210.6%

Occupancy

92.5%91.1%1.4%1.5%

•20% increase in underlying EBITDA compared to pcp2021.

•Aged care business continued to perform well despite COVID-19.

•Sales volumes ahead of pcp2021 despite COVID-19.

•Completion of the acquisition of Waterford in April 2021. A resource consent for 50

independent living apartments has been secured.

•545 units under construction (an increase of 150 on 31 March 2021, “10m2021”).

•Completion of 59 new units at Eden, Gracelands and Stoke.

•Total assets are now $2.1b (10% growth since 10m2021).

•Entry into a sale and purchase agreement to acquire land adjacent to our

Franklin site.

•Successful heavily oversubscribed retail bond offer raising $100m.

•Appointment of two new independent directors Rob Hamilton and Peter Dufaur.

•Appointment of Andrew Buckingham as Group General Manager Development &

Property.

•Interim dividend of 2.1 cents per share announced (30 November 2020: 1.3

cents).This will have a record date of 6 December 2021 and will be paid on 20

December 2021.The Dividend Reinvestment Plan will apply to this dividend.

Highlights

4
Our new directors

The Oceania Board appointed and welcomed Rob Hamilton and Peter Dufauras independent non-executive directors.

The appointments were effective from 17 September 2021.

Rob Hamilton BSc, BCom

Peter Dufaur BProp

Rob is a respected member of the capital

markets and finance community in New

Zealand, with more than 30 years’

experience in senior executive roles.

Rob is currently a Director of Westpac

New Zealand Limited and a Director of

Tourism Holdings Limited (including Chair

of the Audit Committee). He was

previously Chief Financial Officer at

SkyCityEntertainment Group Limited and

a Managing Director and Head of

Investment Banking at Jarden (formerly

First NZ Capital).

Rob is also a member of the Auckland

Grammar School Board of Trustees and

has previously been a Board member on

the New Zealand Olympic Committee.

Rob is a member of the Audit Committee.

Peter has over 25 years’ experience in

the New Zealand property market,

including 10 years as Head of

Development for Goodman Property

Trust. During his time at Goodman

Property Trust, Peter was responsible for

all of the Trust’s development activity

and oversaw more than $1.5 billion of

successful property development.

Peter also sits on several private

enterprise boards, including until

recently, Chair of building products

manufacturer Thermakraft. Peter is

currently the Managing Director of

Mayfair Group Limited, which is involved

in property development, asset

management and funds management

across a wide variety of sectors in the

New Zealand property market.

Peter is a member of the Development

Committee.

5
COVID-19 update

The safety of our staff and residents remain our primary focus.

All Oceania sites were placed into immediate lockdown following the Prime Minister’s

announcement on 17 August 2021.

Increased communications

•Central communications updates delivered daily from the business’ leaders to

site managers

•Ensured consistency and timely information distributed across the group in a

fast-changing environment

Vaccinations

•100% of on-site staff fully vaccinated in accordance with the

Ministry of Health public health orders

•96% of residents fully vaccinated. An additional 2% have received

their first dose

Surveillance testing & staff care

•Over 6,000 saliva tests undertaken on staff between 18 August

and 30 September

•Gratitude payment made to all staff ($350k in aggregate)

•Over 320 vaccinations given to staff and family at pop up facilities

Industry advocacy

•CEO and GGM of Nursing & Clinical Strategy lobbying on behalf of the industry

•Media advocating for families to see loved ones safely

Our response to the Delta outbreak

Key COVID operational information

COVID Costs

•$1.0m of additional costs associated with COVID in 1HY2022

(Saliva testing, PPE, additional staffing and gratitude payment)

Care admissions

•Continued throughout all alert levels

Village admissions

•Resumed from Level 3

6
Oceania leading advocacy during COVID

Oceania’s executive team have been at the forefront of the retirement industry’s public voice

during COVID-19, advocating for staff and resident welfare.

“Oceania Healthcare chief executive Brent Pattison said last

week that the current restrictions were weighing heavily on the

mental health of residents.

"We ask the Government to urgently consider our older citizens

and its definition of 'compassionate grounds' for visitation,

extending that to include what's necessary to support the

positive mental health and well-being of aged-care residents,"

Pattison said.”

“The boss of a retirement village operator is calling on the

Government to allow aged care residents to reconnect with

their loved ones...

“The industry can cater for extended bubbles, safely and

carefully – but we need changes from the Government to

make that possible," Pattison said...

“Pattison said he wants to work collaboratively with the

Government to implement these changes and enable residents

to reconnect with their loved ones.”

“At Oceania Healthcare, which runs more than 40 rest homes

across the country, general manager of nursing and clinical

strategy Frances Hughes said staff were constantly looking at

how to change rosters and change systems.

"It may end up that we can't take the admissions we want. We

will always ensure that our services are safe and that may

mean that we have [fewer] people in our facilities," she said.”

7
Total assets

NZDb

Sales volumes

NZDm

1HY2022 trading highlights

Recurring premiumrevenue underpins our result with DMF and PAC revenue for 1HY2022 of $25.0m, a 35% increase on pcp2021.

Resales volume (units)

New sales volume (units)

Premium revenue

Underlying EBITDA

1

NZDm

6 months to 30 September6 months to 30 November

6 months to 30 September6 months to 30 November

101

123

86

129

84

145

122

101

185

268

208

230

1HY20201HY2021pcp20211HY2022

6 months to 30 September6 months to 30 November

1.5

1.7

2.1

1HY20201HY20211HY2022

SeptemberNovemberNovember

1.The COVID wage subsidy of $1.8m was received in April 2020 and repaid in May 2021.Both 1HY2022 and pcp2021 have been proforma adjusted to exclude the receipt and subsequent repayment of the

wage subsidyrespectively.The unadjusted results for EBITDA are $34.7m and $32.3m respectively for 1HY2022 and pcp2021respectively.

37.1

35.3

30.5

36.5

1HY20201HY2021pcp20211HY2022

16.3

20.4

18.6

25.0

1HY20201HY2021pcp20211HY2022

8
1HY2022 trading highlights (continued)

Our aged care business is underpinned by our premiumisation strategy.

Care suites are now a proven product delivering increasing annuity income streams.

Premiumisation underpins aged care in a challenged environment

Strong resale volume and pricing

1.Note: Unless otherwise stated the comparisons in this section are comparing the 6 monthperiod to 30 September 2021 (1HY2021) with the 6 monthprevious corresponding period to 30 September 2020 (pcp2021).

Group occupancy

92.5%

(91.1% for pcp2021)

$9,500+

EBITDA per bed

($8,000 for pcp2021)

$16,200

EBITDA per bed including care suite

development margin and resale gains

($15,900 for pcp2021)

Premiumisation

Resale margin

20%

Development margin of

26%

- consistent with previous guidance that

margins would moderate as we sell down new

developments at regional sites.

Total ORA sales

in 1HY2022

230

Increase of 22 units

and care suites

(208 for pcp2021)

54%

of our care portfolio is now premium

beds or care suites

Premium care revenue

growth

is driven by increased

DMF capture

($9.0m in 1HY2022 vs

$5.4m in pcp2021).

1HY2022 premium

care revenue

$9.3m

32.7% increase

on pcp2021

New sales

101

(122 in pcp2021)

Resales

129

(86 in pcp2021)

66%

New sales outside

Auckland

(~66% in pcp)

Average apartment resale price now

$811,000

A 15% increase on pcp($708k) and

18% increase on 10m2021($688k)

9
1HY2022 trading highlights (continued)

59 units deliveredat Eden, Gracelands

and Stoke.

545

1

villas, apartments and care

suites currently under construction

in Auckland, Hamilton, Tauranga, Hawkes Bay

Blenheim and Christchurch. An increase of 150

units from 10m2021.

171 units and care suites

on track to be delivered in FY2022. Guidance revised

as Awatere Stage 2 is now advanced into FY2022

(previously FY2023) and Lady Allum is now expected

to deliver in FY2023 due to COVID lockdowns.

Total development pipeline of

1,961 units and care suites

with 74% of this pipeline consented.

We have commenced development at three new sites in 1HY2022, adding 209 new units and care suites under

construction. We now have 545 units and care suites under construction across 8 sites.

1. 8 sites as at 30 September 2021.

2. The dividends are not imputed due to the availability of existing tax losses.

Two acquisitions settled:

Waterford on Hobsonville Point;

additional 26 apartments consentedsince settlement,

more than doubling Stage 1

.

Franklin in Pukekohe; planning underway

including submission of resource consent

Final dividend per share announced of

2.1 cents per share (not imputed

2

).

(1.3 cents interim dividend in 1HY2020)

55% pay out ratio of Underlying NPAT

for the half year period in line with Board policy.

Record date of 6 December 2021.

Payment date of 20 December 2021.

Dividend Reinvestment Plan available.

Development pipeline progressSuccessful retail bond issue

Final dividend declared

Growth Areas

Successfully issued $100m retail bond

in September 2021 (7 year secured fixed rate bonds with a

coupon of 3.30%).

The retail bond offer was fully oversubscribed with

Oceania accepting $25m of oversubscriptions.

This retail bond has given us additional balance sheet

capacity that is currently unutilised.

New partnerships:

Bay of Plenty PPP;Oceania has entered into

an exclusive partnership with Bay of Plenty DHB to

explore and develop a new service model for high

needs and complex aged care residents.

Team capability:

Group General Manager Property &

Development;

Andrew Buckinghamwill be joining

the team in February2022.

10
Existing portfolio

1

1. As at30 September 2021.

2. Includes 235 care studios which may be initially sold with a PAC and may subsequently be sold under an ORA.

43%

20%

36%

1,509

1,803

849

Care

suites

Units

Care

beds

42%

58%

1,140

821

Units &

Care suites

Consented

Care suites

Care

beds

Units

Care

suites

Units

Units & Care suites

Under

Construction

Units & Care suites

Units &

Care suites

Premium

Units &

Care beds

Units &

Care suites

Premium

Units &

Care beds

Development pipeline

Post development portfolio

26%

29%

45%

2,556

1,473

1,654

4,062

1,621

Future development outlook

50% of our existing portfolio is now premium units and care suites as we progress to

~70% premium / 30% standard at the end of our current pipeline.

29%

71%

28%

46%

26%

516

900

545

50%

50%

2,117

2,044

Current & future portfolio composition – remaining “needs” focused

1

Care bedsCare suitesILUsTotal

North Island

1,3905221,1633,075

South Island

4133273461,086

Total Existing

1,8038491,5094,161

DevelopmentPipeline

2

-8211,1401,961

Less Decommissions

(291)(43)(93)(427)

Care Suite Conversions

(39)27-(12)

Net DevelopmentPipeline

(330)8051,0471,522

Total Post Development

1,4731,6542,5565,683

Planned

11
Acquisitions

Waterford and Franklin were settled in 1HY2022 using the proceeds of

our successful $100m capital raise completed in March 2021.

Franklin

1. Future units and care suites at Franklin excludes the yet to be determined yield on additional 1.8 hectares of land under contract.

Pukekohe, Auckland

Settled in May and June 2021

~215

1

Units & Care suites

Waterford

HobsonvillePoint, Auckland

Settled in April 2021

~80

Units & Care suites

Progress update

Post-settlement we have more

than

doubledthe number of

consented apartments in the first

stage of development at

Waterford to 50 (from 24).

Now 7.9ha

in total

Progress update

Post-settlement we have entered into a

conditional sale and purchase

agreement to acquire an additional

1.8ha of land adjacent to the original

acquisition. We are also progressing

resource consent.

12
Our care premiumisation journey

Care

The status of our care suite development pipeline within the Brownfields Earnings Cycle.

EBITDA/bed

T-4T-3T-2T-1TT+1T+2T+3T+4T+5

ConstructConsentCommission

Ramp Up

Maturity

$8-10k

263308132

171

$0-5k

-$10-0k

$20k+

Eden now joined by Meadowbank

and The Sands

174

Number of care suites at each stage of redevelopment

$5-15k

Care at The BayView (opened FY2020)

and Awatere (FY2021)

571 care suites resource consented or under construction.

A further 250 care suites in planning stages comprise the remainder of the 820 care

suites currently in the development pipeline.

13
Gracelands

Hawkes Bay

8 villas completed in September 2021 with the remaining 10 villas completed in

October 2021. This concludes the three stages of development at Gracelands

comprising

50 new villas.

Eden

Auckland

Completed in April 2021

Units & Community centre

49

Developments completed

59 units and care suites completed in 1HY2022, in line with expectations.

Villas

8

14
Developments commenced in 1HY2022

209 units and care suites commenced development in 1HY2022

Redwood

Blenheim

Commenced in May 2021

The Bellevue – Stage 2

Christchurch

Commenced in July 2021

Elmwood

Auckland

Commenced in September 2021

Care suites

57

46

UnitsCare suites

106

Site for new 3 storey

care centre

(~6,300m

2

site)

15
FY2022 scheduled completions

112 units and care suites scheduled for completion in 2HY2022 taking total deliveries for FY2022 to 171.

Awatere

Hamilton

Accelerated and now scheduled to complete in 2HY2022

The BayView 2b

Tauranga

Scheduled to complete in December 2021

Units & Community centre

39

Units

63

16
Other developments under construction

In total there are 545 units and care suites under construction as at 1HY2022, an increase of 150 over 10m 2021.

COVID-19 Alert Level 4 lockdowns in Auckland have delayed Lady Allum which was previously expected to deliver in March 2022.

Lady Allum –Stage 1

Auckland

Scheduled to complete in 1HY2023

Waimarie St

Auckland

Commenced construction in 10m2021

7932

Care suites

Units

113

Care suites

17
Income statement and

segmental performance

Cash flow statement

Balance sheet

Capital structure

Financial

Results.

18
Change in balance date

This is the first half-year results presentation since the change of balance date to 31 March.

1.Oceania changed its balance date to 31 March (previously 31 May) for the financial year ended 31 March 2021.

Prior half-year statutory disclosures were for the 6 months ended 30 November.

The focus of this presentation will be comparing the pro-forma 6 months of

trading to 30 September 2021 with pro-forma comparative 6 month period to 30

September 2020 (“pcp2021” or prior corresponding period, “pcp”)

1

.

The COVID wage subsidy of $1.8m was received in April 2020 and repaid in May 2021.

Both 1HY2022 and pcp2021 have been proforma adjusted to exclude the receipt and

subsequent repayment of the wage subsidy respectively.

Comparison with prior period

Reporting timeline

31 March 2021

10m2021

Statutory reporting

NZDm

6 months to

30 September2021

1HY2022

6 months to

30 November2020

1HY2021

Group Underlying EBITDA ($m)

36.535.3

Underlying NPAT ($m)

27.526.9

31 March 2020

Current balance date

30 September 2021

pcp2021

30 September 2021

1HY2022

Pro-forma comparative period

6 months to 30 September 2020

(pcp2021)

31 May 2020

Prior balance date

30 November 2020

1HY2021

Current half-year reporting

period

6 months to 30 September 2021

(1HY2022)

6 months to 30 SeptemberGrowth

NZDm

2021

1HY2022

2020

pcp2021

Δ

%

Proforma Group Underlying EBITDA ($m)

2

36.530.56.019.7%

Proforma Underlying NPAT ($m)

2

27.522.55.022.2%

Sales volume

2302082210.6%

Occupancy

92.5%91.1%1.4%1.5%

Prior reporting period

6 months to 30 November

2020 (“1HY2021”)

•New Zealand was been subject to Alert Level 3 restrictions or higher for 21 days in

1HY2022 (43 days in pcp2021).

•In addition to national lockdowns the Auckland region has been subject to Alert

Level 3 restrictions or higher for a further 23 days in 1HY2022 (i.e. 44 days in

total; 43 days in pcp2021).

COVID-19 impact on periods

2.The COVID wage subsidy of $1.8m was received in April 2020 and repaid in May 2021. Both 1HY2022 and pcp2021

have been proforma adjusted to exclude the receipt and subsequent repayment of the wage subsidyrespectively.

The unadjusted results for EBITDA and NPAT are $34.7m and 25.8m respectively for 1HY2022 ($32.3m and $24.3m

respectively for pcp2021).

19
Income statement

Total Comprehensive Income for the period of $62.7m.

Key valuation assumptions remained largely consistent from 10m2021 with IP growth

and discount rates unchanged and only minor adjustments to growth rates.

1. Fair value movement includes impact from right of use asset (EverilOrr village). This is a lease arrangement under which Oceania is the village operator. There is a corresponding rental expense of $1.9m (excluded from Underlying Profit). Note EverilOrr also

contributed $1.1m to DMF revenue in 1HY2022 ($1.9m in 10m2020).

DriversAs at 1HY2022As at 10m2021

Investment Property

PPGR – Long Term (low-high)

2.50%3.50%2.50%3.50%

PPGR – Short Term (low-high)

0.50%3.00%0.50%3.00%

Discount Rates (low-high)

14.00%20.00%14.00%20.00%

Average Incoming Price - Villas

$556,674$474,483

Average Incoming Price – Apartments

$850,591$840,817

Property, Plant and Equipment

Cap rate (low-high)

12.00%17.00%12.00%17.00%

EBITDAR per bed (low-high, $000s)

$9.16$16.96$9.00$16.70

Average Incoming Price – Care Suites

$293,889$285,995

Summary of income statement

NZDm

1HY2022

Unaudited

Six months

10m2021

Audited

Ten months

Operating revenue

113.9 175.4

Operating expenses

(106.1)(162.9)

Change in fair value of IP, impairment of PP&E and other

1

39.6 83.3

Operating Profit

47.4 95.7

Finance costs

(4.1)(6.8)

Depreciation (buildings)

(6.3)(8.6)

Depreciation (chattels) and amortisation

(3.5)(5.2)

Profit/(loss) before Income tax

33.5 75.1

Taxation benefit/(expense)

3.5 10.4

Reported Net Profit/(Loss) after Tax

36.9 85.5

Other Comprehensive Income

25.7 82.3

Total Comprehensive income

62.7 167.8

Key IP and PP&E CBRE valuation assumption changes

•As outlined above property price growth rate and discount rate assumptions remained

largely constant in 1HY2022, following significant fluctuations over the past 18 months due

to COVID-19

•Positive fair value movements in 1HY2022 largely driven by the continued sell down of key

development sites, thereby unwinding CBRE’s block discount applied to unsold stock

•DMF revenue increased by 38.0% to $22.7m in 1HY2021 compared to pcp2021 ($16.4m).

20
NZDm

1HY2022

Unaudited

Six months

10m2021

Audited

Ten months

Reported Net profit after tax

36.9 85.5

add: Repayment / (receipt) of wage subsidy

1.8 -

less: Change in fair value of investment property and impairment of PPE

(40.6)(86.5)

add: Impairment of goodwill

0.3 1.2

add: Realised gains on resales

10.6 17.9

add: Realised development margin

15.3 23.8

less: Deferred tax

(3.5)(10.4)

Add: Care suite depreciation

4.8 6.2

add: Rental expenses in relation to right of use asset

1

1.9 4.1

add: Other

-(0.1)

Underlying NPAT

27.5 41.8

add: Depreciation and amortisation (buildings)

1.5 2.4

Add: Depreciation and amortisation (chattels, leasehold improvements

and software)

3.5 5.2

add: Finance costs

3.9 6.8

Underlying EBITDA

36.5 56.2

Underlying earnings

Underlying EBITDA of $36.5m for the 6 month period ended 30 September 2021, a 19.7% increase on pcp2021.

1. Rental expense of $1.9m in 1HY2022 relates to the right of use asset at EverilOrr village. There is a corresponding credit in IP which is also removed as part of this adjustment.

Reconciliation of underlying adjustments Segmental underlying adjustments

NZDm

1HY2022pcp2021Var10m2021

Aged Care (ex. care suite margins)

11.0 9.11.918.5

Retirement Village (incl. care suite margins)

37.3 30.6 6.7 55.1

Other

(11.8)(9.3)(2.6)(17.4)

Underlying EBITDA

36.5 30.5 6.0 56.2

•Underlying EBITDA for 1HY2021 was $6.0m (19.7%) above pcp.

•Consistent with our 10m2021 result, we calculate Underlying NPAT on a basis that adds back

depreciation on care to better reflect the economic substance of our asset base and assists

with comparability to our peers.

•The COVID wage subsidy of $1.8m was received in April 2020 and repaid in May 2021. Both

1HY2022 and pcp2021 have been proforma adjusted to exclude the receipt and subsequent

repayment of the wage subsidyrespectively. The unadjusted results for EBITDA are $34.7m

and $32.2m for 1HY2022 and pcp2021respectively.

21
Premium revenue

NZDm

Occupancy ratesAged care underlying EBITDA

NZDm

1HY2022pcp2021Var10m2021

Total aged care operating revenue

93.5 85.0 8.5 147.1

Total aged care expenses

(84.3)(74.1)(10.2)(128.6)

Aged Care Underlying EBITDA

9.2 10.9 (1.7)18.4

Proforma adjustment related to wage subsidy

repayment / (receipt)

1.8(1.8)

3.6-

Proforma Aged Care Underlying EBITDA

11.09.11.918.4

Proforma EBITDA per care bed / suite

(all sites)

1

9,559 8,017 1,5429,569

Plus: Other aged care related earnings included within the Village Segment

2

Care suite development margin

4.8 5.8 (1.0)9.2

Care suite resale gains

3.3 3.2 0.1 6.4

Total Aged Care related Underlying EBITDA

19.1 18.2 0.934.0

Total Aged Care related Underlying EBITDA per bed

/ suite (all sites)

16,291 15,933 35817,659

Care segment

EBITDA per bed of over $9,500 per bed was an increase of 19.2% on pcp2021. Key drivers of care performance were group

occupancy of 92.5% and continued increases in premium revenue continues as our care suite portfolio matures.

1. Based on all occupied beds across all care sites, including centresthat are ramping up / down as a result of past / future development.

2. Development margin & resale gains on care suites are included within the Village Segment for underlying profit and statutory reporting

purposes as the ORAs are issued by Oceania Village Company Limited. As these margins are in lieu of daily premium charges under the

traditional model, these earnings are aggregated above to present a more complete picture for the Care segment.

91.6%

92.1%

91.1%

92.5%

94.2%

93.2%

92.4%

93.9%

1HY20201HY2021pcp20211HY2022

Group OccupancyOccupancy of sites not affected by development

6 months to 30 September6 months to 30 November

1.8

2.1

2.1

2.4

3.5

5.4

4.9

7.0

5.3

7.5

7.0

9.3

1HY20201HY2021pcp20211HY2022

PAC RevenueCare Suite DMF

6 months to 30 September6 months to 30 November

22
Village underlying EBITDA

NZDm

1HY2022pcp2021Var10m2021

Villa and apartment DMF

15.6 11.5 4.1 22.1

Retirement village service fees

3.7 3.1 0.6 5.2

Other revenue

1.4 1.4 -2.4

Total retirement village operating revenue

20.7 15.9 4.8 29.7

Realised gains on resales

10.6 6.2 4.4 17.9

Realised development margin

15.3 16.8 (1.5)23.8

Village site operating expenses

(9.7)(8.5)(1.2)(14.3)

Resident share of capital gains

0.4 0.2 0.2 (2.0)

Total retirement village expenses

(9.3)(8.3)(1.0)(16.4)

Retirement village Underlying EBITDA

37.3 30.6 6.7 55.1

Total resale volume

129 86 43 194

Total new sales volume

101 122 (21)194

Total sales volume

230 208 22 388

Less: Aged care related earnings included within the Village Segment

Care suite development

margin & resale gains

(8.1)(9.0)0.9 (15.6)

Village Underlying EBITDA (ex. care)

29.3 21.6 7.7 39.5

Villa and apartment DMF revenue

NZDm

Village segment

Sales volumes ahead of pcp2021 and delivering improved DMF capture despite COVID-19.

•Total 230 sales in 1HY2022, a 10.6% increase on pcp2021.

•Continue to see strong growth in DMF in the Village segment as

developments sell down and resales occur at higher price point.

•See further analysis of margins and volumes on the following pages.

6 months to 30 September

6 months to 30 November

11.0

12.9

11.5

15.6

1HY20201HY2021pcp20211HY2022

23
Average new sales prices

NZD000s

New sales volumes and margins Gross new units delivered

Developments – key indicators

Development margin of 26% is consistent with 10m2021. This development margin and our average sales prices reflect the higher

proportion of new stock we are selling outside of Auckland at sites like Green Gables, The BayViewand The Bellevue.

•49 apartments completed at Eden during 1HY2021.

•10 villas completed at Gracelands (8) and Stoke (2). 10 further villas subsequently completed at

Gracelands in October.

•171 units and care suites are scheduled to complete in FY2022.

•We have previously guided that “margins are expected to moderate going forward as we sell

down sites in regional areas”. 66% of new sales in 1HY2022 were outside of Auckland (66%

pcp; 72% 10m2021 and 44% 1HY2020).

•Key regional new sales sites included Gracelands (villas); The BayView (apartments and care

suites), Green Gables (apartments and care suites); The Bellevue (care suites and apartments);

and Awatere (care suites).

▬Average apartment price decrease to $896k ($1.0m in pcp) represents the impact of lower

sales prices for apartments at these regional sites compared to pcpwhere 56% of

apartment sales were at The Sands and Meadowbank in Auckland.

▬Average price of care suites also includes the sale of care suite conversions at other

locations including Eldon, Atawhai, and Holmwood, also regionally based.

3

16

19

13

26

44 38

44

55

85

65

44

36.6%

24.6%

27.1%

25.7%

-

10.0%

20.0%

30.0%

40.0%

-

40

80

120

160

200

1HY20201HY2021pcp20211HY2022

VillaApartmentCare SuiteDevelopment Margin

6 months to September6 months to 30 November

583

463

456

488

1,164

962

1,017

896

339

227

239

301

1HY20201HY2021pcp20211HY2022

VillaApartmentCare Suite

6 months to 30 September6 months to 30 November

Units

6 months to November

6 months to

September

1HY2022

1HY20201HY2021

Villas

10-10

Apartments

-2849

Care suites

9061 -

Total

1008959

24
Resales volume regional breakdown

Units

Resales prices

NZD000s

Closing stock (incl. stock under application) –Resales

Units

Resales volumes and margins

Resales – key indicators

Resale volumes of 129 in 1HY2022 represents a 50% increase compared to pcp2021.

Apartment resale prices averaged $811k, an increase of 14.5% on pcp2021.

6 months to 30 September6 months to 30 November

6 months to 30 September6 months to 30 November

427

455

468

524

657

630

708

811

245

310

311

304

1HY20201HY2021pcp20211HY2022

VillaApartmentCare Suite

46

53

37

47

7

16

9

25

11

17

15

20

30

17

14

21

7

20

11

16

1HY20201HY2021pcp20211HY2022

AucklandWaikato / BOPOther NIChristchurchOther SI

6 months to 30 September6 months to 30 November

26

42

12

17

35

18

37

39

40

1HY20201HY20211HY2022

VillaApartmentCare Suite

6 months to 30 September

6 months to 30 November

22

27

15

27

17

22

9

18

62

74

62

84

30.3%

23.9%

13.0%

17.3%

22.4%

25.6%

16.6%

12.8%

-

10.0%

20.0%

30.0%

40.0%

-

30

60

90

120

150

1HY20201HY2021pcp20211HY2022

VillaApartmentCare Suite

ILU Resales MarginCare Suite Resale Margin

25
Cash flow

Operating cash flow of $52.5m for 1HY2022compared to $96.0m for 10m2021.

Operating cash flow was driven by first time sales proceeds of $59.1m.

Statement of cash flows

NZDm

1HY202210m2021

Receipts from customers

97.0 142.3

Payments to suppliers and employees

(113.1)(153.3)

Rental payments in relation to right of use asset

(1.9)(4.1)

Receipts from new ORA

109.3 171.4

Payments for outgoing ORA

(35.7)(52.2)

Net interest

(3.3)(8.0)

Net cash inflow from operating activities

52.5 96.0

Payments for PPE and intangible assets

(25.2)(36.3)

Payments for investment property &

investment property under development

(61.1)(66.0)

Payments for business assets

(56.2)-

Net cash outflow from investing activities

(142.5)(102.3)

Proceeds from borrowings

170.9 90.3

Repayment of borrowings

(154.8)(218.5)

Dividend paid

(9.2)(6.3)

Proceeds from bond & share issues (net of transaction costs)

20.0 203.1

Net cash inflow from financing activities

26.9 68.5

Net increase / (decrease) in cash and cash equivalents

(63.1)62.3

Cash & equivalents at beginning of period

79.9 17.6

Cash and cash equivalents at end of period

16.8 79.9

•First time sales receipts at development sites of $59.1m

(c.f. $92.7m in 10m2021).

•The rental payment of $1.9m for the right of use asset relates to the

arrangement at Everil Orr. An equal receipt is included in receipts from

new ORAs.

•Cash outflows from investing activities included settlement of Waterford

($56.2m) and Franklin ($17.5m) in 1HY2022. Development capex spend was

again impacted as development sites were disrupted by COVID-19 Level 4

lockdown.

Operating cash flow

NZDm

6 months to 30 September6 months to 30 November

57.0

74.5

52.5

1HY20201HY20211HY2022

26
Oceania has been active in M&A and capital markets

Over 1HY2022 Oceania has completed two M&A transactions and raised both equity and debt

capital to position the business for growth

“Oceania Healthcare had plenty of interest in its $20

million retail offer, which closed oversubscribed.

The listed aged care operator received applications from

retail investors of about $50m for the offer...

“The retail offer formed part of Oceania’s equity raise

announced on March 23, which also included a $80m

placement to institutional investors, at $1.30 a share.”

“Oceania Healthcare said it planned to raise about $100

million to fund the acquisition of a retirement village,

Waterford on HobsonvillePoint.

The money would also be used to buy 6.1 hectares in

Franklin, including 2.0 hectares of land currently leased

to Oceania and 4.1 hectares of bare land adjacent to the

site...

“Oceania has initial plans in place to redevelop the

combined site into an integrated village, offering villa

and care suite accommodation options with more than

200 residences upon completion.”

“NZX-listed aged care provider Oceania Healthcare is

raising up to $100m through a bond offer to acquire and

develop sites across New Zealand.

The company is offering $75m in seven-year secured

fixed rate bonds, with the ability to accept up to $25m

oversubscriptions...

“The bond issue will be used to diversify debt, repay

bank debt and facilitate future growth, including funding

its current pipeline and the acquisition of new

development sites.”

27
NZDm

As at

30 September

2021

As at

31 March

2021

Property, plant and equipment (including WIP)

645.1 604.1

Investment property (including WIP)

1,335.9 1,141.5

Sub Total

1,981.0 1,745.6

less: Investment property ORA Gross Up

(565.8)(481.9)

less: Adjustment for CBRE –care suites

(121.3)(106.5)

add: Other

(6.6)(15.1)

CBRE plus WIP

1,287.3 1,142.1

less: Net Debt

(342.7)(258.9)

Net Adjusted Value

944.6 883.2

Shares on Issue

705.7 689.3

Net Adjusted Value per Share

1.341.28

Balance sheetNet adjusted value (“NAV”)

NZDm

As at

30 September

2021

As at

31 March

2021

Assets

Cash and trade receivables

74.3 127.6

Property, plant and equipment

645.1 604.1

Investment properties and right of use asset

1,335.9 1,141.5

Intangible assets

9.1 10.6

Total assets

2,064.3 1,883.7

Liabilities

Refundable occupation right agreements

716.5 618.4

Borrowings and lease liability

1

359.5 338.8

Other liabilities

81.4 91.3

Total liabilities

1,157.4 1,048.5

Equity

Contributed Equity

700.7 675.6

Retained Deficit

(64.5)(85.4)

Reserves

270.7 245.0

Total equity

906.9 835.2

Net tangible assets

897.9 824.4

Balance sheet

Total assets increased by $181m from 31 March 2021 driven by growth in the value of retirement

village and care properties through acquisitions and continued development

1. Includes lease liabilities of $8.8m as at30 September 2021 ($11.5m as at 10m2021).

•NAV of $1.34 per share as at 1HY2022.

•The NAV reflects the value of existing sites, plus the land and WIP at

development sites. As such, the present value of net development cash

flows and future earnings at development sites are excluded.

28
Debt facilitiesFacility limit

Drawn amount

as at 1HY2022

Headroom

General / corporate

$85.0m$6.0m $79.0m

Development facility

$265.0m$119.8 m$145.2m

Retail Bonds

$225.0m$225.0m -

Total limits / borrowings

$575.0m$350.8m$224.2m

Cash

n/a($16.8m)n/a

Finance leases

n/a$8.8mn/a

Total net debt

$342.8m

Following a second successful retail bond issue of $100m in September 2021, Oceania has $241m of debt

headroom providing significant balance sheet capacity to execute on our growth strategy

Periodending

As at

1HY2022

As at

10m2021

Net debt

$342.8m$261.5m

Net debt / (net debt + equity)

27.4%23.9%

Loan to value ratio

30.3%30.7%

Net debt Credit metrics

•In March 2021 Oceania announced an equity raise that included an $80m

Institutional Placement (successfully completed prior to 31 March balance

date) and a $20m Retail Offer (successfully completed in April 2021).

•In September 2021 Oceania successfully completed its second Retail Bond

issuance of $100m (including full $25m of oversubscriptions), providing

further diversity of funding and tenor.

•Bank facility limits are interchangeable with balances related to land

acquisitions and consenting activity transferred from the General Facility to

Development Facility on commencement of development.

Debt tenor profile

(NZDm)

Capital structure

100.0

350.0

125.0

FY2022FY2023FY2024FY2025FY2026FY2027FY2028FY2029

Bank facilitiesRetail Bonds

01
Portfolio summary

02

Development pipeline

03

Reconciliation of portfolio

movements

04

Summary of unit sales

05

Embedded value

06

Capital expenditure

07

Reconciliation of resales

cash flow

08

Definition of Underlying NPAT

09

Glossary

10

Important notice and disclaimer

Appendices.

30
FacilityRegionCare bedsCare suitesVillage unitsTotal

NORTH ISLAND

Totara ParkRodney

--3030

The SandsNorth Shore

-

4464108

GreenvalleyLodgeNorth Shore

50--50

Lady AllumNorth Shore

7215129216

TeManaNorth Shore

46--46

AmberwoodWaitakere

67--67

WaterfordWaitakere

--100100

EdenAuckland

-6789156

EverilOrr

1

Auckland

52--52

MeadowbankAuckland

-

63193256

WesleyAuckland

51--51

ElmwoodManukau

11148129288

St Johns AucklandManukau

--1818

TakaniniManukau

91--91

FranklinFranklin

44--44

Awatere (formerly Trevellyn)Hamilton

-9040130

WhitiangaWhitianga

53-1063

ElmswoodTauranga

38--38

The BayViewTauranga

-8195176

OhinemuriPaeroa

68-876

Victoria PlaceTokoroa

51--51

St Johns WoodTaupo

372518

80

WharerangiTaupo

47-2168

DuartHastings

66--66

EversleyHastings

50-656

GracelandsHastings

8111109201

AtawhaiNapier

582546129

WoburnHawke's Bay

33--33

EldonParaparaumu

8411-95

EldersleaUpper Hutt

1022212136

HeretaungaUpper Hutt

3820-58

Hutt GablesUpper Hutt

--4646

FacilityRegionCare bedsCare suitesVillage unitsTotal

SOUTH ISLAND

Marina CovePicton

--2222

Green GablesNelson

-6140101

OtumaramaNelson

327-39

StokeNelson

--

116

116

WhareamaNelson

71--71

RedwoodBlenheim

451646107

WoodlandsTasman

30203686

HolmwoodChristchurch

2917-46

MiddleparkChristchurch

3321-54

Palm GroveChristchurch

315432117

The OaksChristchurch

693632137

The Bellevue

(formerly Windermere)

Christchurch

-712293

Addington LifestyleChristchurch

7324-97

TOTAL (NORTH AND SOUTH ISLANDS)

1,8038491,5094,161

Portfolio summary

01

As at 30 September 2021

1. EverilOrr excludes 49 ILUs completed in FY18 and FY20 that were developed by the Methodist Mission.

31
SitesStageStatusILUsCare suitesGross unitsNet unitsNotes

Meadowbank

Stage 6Consented

-363636

Awatere(formerly Trevellyn)

Stage 2Under Construction

63-6363

Scheduled for completion 2HY2022

Stage 3Consented

71-7171

The BayView(formerly Melrose)

Stage 2bUnder Construction

39-3939

Scheduled for completion 2HY2022

Stages 3-6Consented

135-135135

The Bellevue (formerly Windermere)

Stage 2Under Construction

46-4646

Commenced construction 1HY2022

Lady Allum

Stage 1Under Construction

113113(17)

Scheduled for completion 1HY2023

Stage 2Consented

696969

Stage 3Consented

686868

Gracelands

Stage 3Under Construction

101010

Completed in 2HY2022 (October 2021)

Redwood

Under Construction

575757

Commenced construction 1HY2022

Eversley

Consented

585852

Whitianga

Stage 2Consented

888

Elmwood

Stage 1UnderConstruction

10610676

Commenced construction 1HY2022

Stage 2-3Consented

229229133

Stage 4Planned

818170

Waimarie Street

Under Construction

7932111111

Other

Hawkes BayPlanned

26467272

NelsonPlanned

272710

AucklandPlanned

110108218218

VariousConsented

57169226148

VariousPlanned

229611859

Total Consented/under construction

8745711,4451,105

Total Pipeline

1,1408211,9611,534

Development pipeline

02

Status as at 30 September 2021

32
As at

FY2020

Changes

in existing

capacity

Conversion

of beds to

care suites

Conversion

of units to

care suites

New units

acquired

New units

delivered

Changes in

pipeline –gross

units added

Changes in

pipeline –

decommissions

As at

10m2021

Existing

Care beds

1,807(4)1,803

Care suites

8472849

Units

1,36710059(17)1,509

Pipeline

Care beds

(316)(14)(330)

Care suites

76540805

Units

1,065(59)24171,047

Total

5,535(4)20100064(14)5,683

Reconciliation of portfolio movements

03

1. Changes in capacity and pipeline now includes forecast care suite conversions in the pipeline. Totals as at 30 September 2021reconcile to both the total existing and future post development portfolios on slide 10.

Movements in gross pipeline since 10m2021

1,956

Units

1,951

Units

49

Units

8

Units

26

Units

36

Units

33
Resales

6 months to 30 November6 months to 30 September

201820192020202120202021

Villa

32 24 22 27

15 27

Apartment

12 8 17 22

9 18

Care suite

25 47 62 74

62 84

Total

69 79 101 123 86 129

Average resale margin

28.4% 23.4% 23.0% 20.8% 22.4% 25.6%

New Sales

6 months to 30 November6 months to 30 September

201820192020202120202021

Villa

9 17 3 16

19 13

Apartment

7 24 26 44

38 44

Care suite

7 24 55 85

65 44

Total

23 65 84 145 122 101

Average development margin

36.4% 29.5% 36.6% 24.6% 27.1% 25.7%

Average resale gain per unit / care suite

6 months to 30 November6 months to 30 September

201820192020202120202021

Villa

127,926 148,958 137,591 118,944

123,867 182,352

Apartment

96,542 75,875 189,112 138,682

127,222 135,333

Care suite

56,480 37,606 31,847 53,642

51,573 39,036

Average resale gain

96,582 75,310 81,350 83,187 72,099 82,469

Summary of unit sales

04

34
Embedded value

05

1. Calculated as the current/estimated sale or resale price of all units/care suites as determined by CBRE.

2. Value of unsold stock represents the sales prices of units/care suites which are not under contract, as they are either newlyconstructed or have been bought back from the previous outgoing residents.

The embedded value in our portfolio has increased 27.6% to $330.2m as at 1HY2022 and will underpin the

future realisationof cash flows from deferred management fees and resale gains.

Summary of Embedded Value Calculation

Embedded Value

NZDm

•Embedded value in Oceania’s portfolio is $330.2m, up 27.6% on 10m2021.

•Embedded value includes:

•$178.5m of accrued DMF cash flows to be realised; and

•$151.6m of resale gains.

•The growth in embedded value primarily reflects the acquisition of

Waterford, as well as growth in our portfolio, migration to our standard

contractual terms at existing villages and a higher price point for the sale

and resale of units and care suites.

142.7 152.3 178.5

103.8

106.5

151.6

246.5

258.8

330.2

1,571

1,646

1,821

-

750

1,500

2,250

3,000

-

100

200

300

400

1HY202110m20211HY2022

Accrued DMFEmbedded Resales GainsNumber of Units (rhs)

NZDm

As at

1HY2022

As at

10m2021

As at

1HY2021

Estimated sale/resale price of all units

1

1,207.9 1,064.9

920.9

less: Unsold stock

2

(225.6)(248.8)

(139.0)

less: Resident liabilities (contractual)

(652.1)(557.3)

(535.5)

equals: Embedded value

330.2 258.8

246.5

35
Capital expenditure

06

Significant increase in capital expenditure in 1HY2022 relative to pcpdue to the acquisitions of

Waterford and Franklin, as well as an increase in Oceania’s development activity

Breakdown of Capital Expenditure

NZDm1HY20221HY2021

Acquisitions

66.7 0.4

Development capital expenditure

71.0 50.8

Remediation expenditure

--

Care conversion & premium room upgrades

-1.6

Maintenance capital expenditure

- Aged care

2.1 3.0

- Retirement village

1.8 2.4

- IT and other

0.8 1.9

Total conversion and maintenance

4.8 8.9

Total capex per statutory cashflow statement

142.5 60.1

Assets under finance leases

2.7 0.4

Total capex (incl. assets under finance leases)

145.2 60.5

36
Reconciliation of resales cash flow

07

1. Net Buybacks is the difference between the gross ORA payments made in relation to units bought back (and not resold) during the year and the gross ORA receipts from units resold during the year that were bought back in prior financial years.

NZDm

1HY20221HY2021

Receipts from New ORAs

109.3 113.4

less: Payments for Outgoing ORAs

(35.7)(29.9)

less: Cash Inflow From New Sales

(59.1)(65.1)

Net Resales Cash flow

14.6 18.5

Made up of:

Resale Gains

10.6 10.4

DMF Realised

10.2 7.2

add: Net Deferred Cash Settlements

(3.1)(0.5)

less: Development Buybacks

(1.8)(1.4)

less: Net Buybacks

1

(1.1)3.3

less: Resident Share of Capital Gains

(0.3)(0.5)

less: Other Cash amounts paid/received from resales

--

Net Cash flows from Resales

14.6 18.5

Reconciliation of resales cash flow

37
Definition of Underlying NPAT

08

Underlying Profit (or Underlying NPAT)

Underlying Profit is a non-GAAP measure used by the Group to monitor financial performance and is a

consideration in determining dividend distributions. Underlying profit measures require a methodology and a

number of estimates to be approved by Directors in their preparation. Both the methodology and the

estimates may differ among companies in the retirement village sector that report underlying financial

measures. Underlying profit is a measure of financial performance and does not represent business cash flow

generated during the period.

Oceania calculates Underlying Profit by making the following adjustments to Net Profit after Tax:

•Removing the change in fair value of investment properties (including right of use investment property

assets) and any impairment or reversal of impairment of property, plant and equipment;

•Removing any impairment of goodwill;

•Removing any gains or loses from the sale or decommissioning of assets;

•Removing any rental expenditure in relation to right of use investment property assets;

•Adding back the Directors’ estimate of realised gains on resale of occupation right agreement units and

care suites;

•Adding back the Directors’ estimate of realised development margin on first sale of new ORA units or care

suites following the development, or conversion of an existing care bed to a care site or conversion of a

rental unit to an ORA Unit;

•Adding back depreciation on care suites; and

•Adding back the deferred taxation component of taxation expense so that only current tax expense is

reflected.

Resale Gain

Directors’ estimate of realised gains on resales of ORA units and care suites (i.e. the difference between the

incoming residents ORA licence payment and the ORA licence payment previously received from the outgoing

resident) is calculated as the net cash flow received, and receivable, at the point that the ORA contract

becomes unconditional and has either ‘cooled off’ or where the resident is in occupation at balance date.

Development Margin

The Directors’ estimate of realised development margin is calculated as the cash received, and receivable, in

relation to the first sale of new ORA units and care suites, at the point that the ORA contract becomes

unconditional and has either ‘cooled off’ or where the resident is in occupation at balance date, less the

development costs associated with developing the ORA units and care suites.

•Construction costs directly attributable to the relevant project, including any required infrastructure (e.g.

roading) and amenities related to the units (e.g. landscaping) as well as any demolition and site

preparation costs associated with the project. The costs are apportioned between the ORA units and care

suites, in aggregate, using estimates provided by the project quantity surveyor. The construction costs for

the individual ORA units or care suites sold are determined on a pro-rated basis using gross floor areas of

the ORA units and care suites;

•An apportionment of land valued based on the gross floor area of the ORA units and care suites developed.

The value for Brownfield development land is the estimated fair value of land at the time a change of use

occurred (from operating as a care facility or retirement village to a development site), as assessed by an

external independent valuer. Greenfield development land is valued at historical cost; and

•Capitalised interest costs to the date of project completion apportioned using the gross floor area of ORA

units and care suites developed.

Development costs do not include:

•Construction, land (apportioned on a gross floor area basis) and interest costs associated with common

areas and amenities or any operational or administrative areas.

The Directors’ estimate of development margin for conversions of care beds to care suites and rental units to

ORAs is calculated based on the difference between the ORA licence payment received on the settlement of

sales of newly converted ORA units and care suites and the associated conversion costs. Conversion costs

comprise:

•In the case of conversion of care beds to care suites, the actual refurbishment costs incurred; and

•In the case of conversions of rental units to ORA units, the actual refurbishment costs incurred and the fair

value of the rental unit prior to conversion.

38
Glossary

09

Care suite

A room or studio certified for the provision of care by the Ministry of Health which has been licensed

under an ORA.

DMF

Deferred Management Fees, charged under an ORA, of a maximum of 30% of the Occupation Licence

Payment, which are deducted from the refund paid to the departing resident upon resale of the unit or

care suite. These are in consideration for the right to use communal facilities etc over the entire length

of stay.

DRP

Dividend Reinvestment Plan.

FY20XX

12 monthaudited financial year. For the purposes of this presentation, FY20XX will always refer to

financial years ended 31 March 20XX, as they have been defined in previous disclosures.

ILU

Independent living units (villas and apartments) licensed under an ORA.

IP

Investment Property.

IP0

Initial Public Offering (of shares in Oceania).

NPAT

Net Profit After Tax.

ORA

An occupation right agreement that confers on a resident the right to occupy a unit or care suite

subject to certain terms and conditions set out in the agreement.

PAC

Premium accommodation charge on a care bed for accommodation provided above the mandated

minimum.

pcp

6 monthperiod ended 30 September 2020 (i.e.the “prior corresponding period”

to the 6 monthperiod ended 30 September 2021).

PPE

Property, Plant and Equipment.

PPGR

Property Price Growth Rate.

Resale Margin

Resale gain, as included in the definition of underlying profit, divided by the ORA licence payment

previously received from the outgoing resident.

Unit

Includes independent villas and apartments.

WIP

Work in progress.

10m20XX

10 monthperiod of trading. For the purposes of this presentation, 10m20XX will always refer to 10

monthtrading periods ended 31 March 20XX.

39
Important notice and disclaimer

10

This presentation has been prepared solely by Oceania Healthcare Limited ("Oceania"). You must read

this disclaimer before making any use of this presentation and the accompanying material or any

information contained in it ("Document").

The presentation includes non-GAAP financial measures for development sales and resales which assist

the reader with understanding the volumes of units settled during the period and the impact that

development sales and resales during the period had on occupancy as at the end of the period.

The addition of totals and subtotal within tables and percentage movements may differ due to rounding.

The information set out in this Document is an overview and does not contain all information necessary to

make an investment decision. It is intended to constitute a summary of certain information relating to the

performance of Oceania for the period ending 30 September 2021. Please refer to the Financial

Statements for the period ended 30 September 2021 that have been released along with this presentation.

The information in this presentation does not purport to be a complete description of Oceania. In making

investment decisions, investors must rely on their own examination of Oceania, including the merits and

risks involved. Investors should consult their own legal, tax and/or financial advisors in connection with

any acquisition of financial products.

The information contained in this presentation has been prepared in good faith by Oceania. No

representation or warranty, expressed or implied, is made to the accuracy, adequacy or reliability of any

statements, estimates or opinions or other information contained in this presentation, any of which may

change without notice. To the maximum extent permitted by law, Oceania, its directors, officers,

employees and agents disclaim all liability and responsibility (including without limitation any liability

arising from fault or negligence on the part of Oceania, its directors, officers, employees and agents) for

any direct or indirect loss or damage which may be suffered by any person through the use of or reliance

on anything contained in, or omitted from, this presentation.

This presentation is not a product disclosure statement, prospectus, investment statement or disclosure

document, or an offer of shares for subscription, or sale, in any jurisdiction.

Receipt of this Document and/or attendance at this presentation constitutes acceptance of the terms set

out above in this disclaimer.

---

Oceania Healthcare Limited
Results announcement

(for Equity Security issuer/Equity and Debt Security issuer)

Updated as at 17 October 2019


Results for announcement to the market

Name of issuer Oceania Healthcare Limited

Reporting Period 6 months to 30 September 2021

Previous Reporting Period 10 months to 31 March 2021

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$113,935 [na – periods not comparable]

Total Revenue $113,935 [na – periods not comparable]

Underlying earnings before

interest, tax, depreciation

and amortisation

$36,467 [na – periods not comparable]

Total net profit/(loss) $36,940 [na – periods not comparable]

Total Comprehensive

Income

$62,655 [na – periods not comparable]

Interim/Final Dividend

Amount per Quoted Equity

Security

2.1 cents

Imputed amount per Quoted

Equity Security

Not applicable

Record Date 6 December 2021

Dividend Payment Date 20 December 2021

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security

$1.27 $1.20

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Please refer to attached documents (unaudited consolidated

financial statements and interim report, media release and

results presentation).

Authority for this announcement

Name of person


authorised

to make this announcement

Anna Thorburn

Contact person for this

announcement

Anna Thorburn

Contact phone number +64 9 361 0350



Contact email address Anna.Thorburn@oceaniahealthcare.co.nz

Date of release through MAP


29/11/2021


Unaudited financial statements accompany this announcement.

---

Oceania Healthcare Limited
Distribution Notice


Updated as at 18 December 2019




Please note: all cash amounts in this form should be provided to 8 decimal places


Section 1: Issuer information

Name of issuer Oceania Healthcare Limited

Financial product name/description Ordinary Shares

NZX ticker code OCA

ISIN (If unknown, check on NZX

website)

NZOCAE0002S0

Type of distribution

(Please mark with an X in the

relevant box/es)

Full Year Quarterly

Half Year X Special

DRP applies X

Record date 06/12/2021

Ex-Date (one business day before the

Record Date)

03/12/2021

Payment date (and allotment date for

DRP)

20/12/2021

Total monies associated with the

distribution

1


$14,819,823

Source of distribution (for example,

retained earnings)

Retained Earnings

Currency NZD

Section 2: Distribution amounts per financial product

Gross distribution

2

0.02100000

Gross taxable amount

3

0.02100000

Total cash distribution

4

0.02100000

Excluded amount (applicable to listed

PIEs)

Na

Supplementary distribution amount Na

Section 3: Imputation credits and Resident Withholding Tax

5


Is the distribution imputed No imputation


1

Continuous issuers should indicate that this is based on the number of units on issue at the date of the form

2

“Gross distribution” is the total cash distribution plus the amount of imputation credits, per financial product, before the deduction of

Resident Withholding Tax (RWT).

3

“Gross taxable amount” is the gross distribution minus any excluded income.

4

“Total cash distribution” is the cash distribution excluding imputation credits, per financial product, before the deduction of RWT.

This should include any excluded amounts, where applicable to listed PIEs.

5

The imputation credits plus the RWT amount is 33% of the gross taxable amount for the purposes of this form. If the distribution is

fully imputed the imputation credits will be 28% of the gross taxable amount with remaining 5% being RWT. This does not constitute

advice as to whether or not RWT needs to be withheld.

If fully or partially imputed, please
state imputation rate as % applied

6


Na

Imputation tax credits per financial

product

Na

Resident Withholding Tax per

financial product

0.00693000

Section 4: Distribution re-investment plan (if applicable)

DRP % discount (if any)

2.5%


Start date and end date for

determining market price for DRP

03/12/2021 09/12/2021

Date strike price to be announced (if

not available at this time)

10/12/2021

Specify source of financial products to

be issued under DRP programme

(new issue or to be bought on market)

New Issue

DRP strike price per financial product

[TBC]

Last date to submit a participation

notice for this distribution in

accordance with DRP participation

terms

07/12/2021

Section 5: Authority for this announcement

Name of person


authorised to make

this announcement

Anna Thorburn

Contact person for this

announcement

Anna Thorburn

Contact phone number +64 9 361 0350

Contact email address Anna.Thorburn@oceaniahealthcare.co.nz

Date of release through MAP


29/11/2021






6

Calculated as (imputation credits/gross taxable amount) x 100. Fully imputed dividends will be 28% as a % rate applied.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.